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CORA ERIN SMILEY. Interactions between stress, ethanol, and THC exposure 
and effects on prefrontal reliant signaling and behavior. (Under the direction of 
JUSTIN T. GASS and L. JUDSON CHANDLER). 
  
Post-traumatic stress disorder (PTSD) and substance use disorder (SUD) 
are two highly prevalent and highly debilitating psychological conditions that often 
occur comorbidly. In accordance with the self-medication hypothesis, drugs like 
alcohol and cannabis are used following exposure to a traumatic event to acutely 
reduce anxiety, but, in the long term, these substances cause impairments in 
learning and memory processes in the prefrontal cortex and reduce the 
effectiveness of therapeutic treatments for these disorders. As such, the 
overarching hypothesis of this dissertation is that exposure to stress, alcohol, and 
cannabis lead to alterations in learning and memory due to modifications in 
prefrontal cortex signaling, and it is further hypothesized that these impairments 
can be reversed by normalizing glutamatergic function in this region. These 
experiments were divided into three main branches of study using behavioral 
pharmacology as well as optogenetics and fiber photometry to investigate the 
deleterious effects of stress, cannabis, and alcohol exposure on cognitive 
functioning and glutamate signaling in the prefrontal cortex. In the first set of 
studies, restraint stress was followed by set-shifting and alcohol self-administration 
behavioral tasks to examine stress-induced changes in cognitive flexibility and 
drug seeking behavior respectively. These experiments established stress induced 




increases in ethanol seeking and relapse like behavior as well as impairments in 
cognitive flexibility. The second set of studies established the detrimental effects 
of alcohol exposure on fear learning during extinction training. Further, this effect 
was shown to be dependent on glutamatergic activity in the prefrontal cortex using 
microinjection and optogenetic studies. In the third set of studies, THC vapor and 
chronic ethanol administration led to deficits in prefrontal cortex reliant behaviors 
including cognitive flexibility, ethanol seeking, and responses to fear stimuli, and 
fiber photometry was used to measure effects of these drugs on prefrontal cortex 
glutamate signaling. Additionally, the pharmaceutical compounds CDPPB and N-
acetylcysteine (NAC) were used to pharmacologically reverse the behavioral and 
signaling impairments that occur as a result of alcohol and cannabis exposure 
respectively. Taken together, the data presented within this dissertation highlight 
the effects of alcohol and cannabis on prefrontal cortex-reliant signaling and 
behavior and use clinically available therapeutics to treat these deficits in a model 
of PTSD/SUD comorbidity. 














Post-Traumatic Stress Disorder and Comorbidities 
Post-traumatic stress disorder was first recognized as a psychiatric disorder 
in the DSM-III published in 1980, but its symptomology has been ascribed to a 
number of different syndromes that have been defined throughout history (Marc-
Antonie Crocq 2000). When examining sample populations, lifetime prevalence of 
traumatic event exposure reaches approximately 70-89% with instances of 
physical or sexual assault, witness of a violent or accidental death, and experience 




of a disaster or accident being the most commonly reported traumas (Kilpatrick et 
al. 2013, Benjet et al. 2016). While a high percentage of the population reports 
exposure to a traumatic event, approximately 25-30% of these patients will develop 
PTSD (Spottswood et al. 2017). The criterion for a PTSD diagnosis spans 20 
symptoms that include hyperarousal, negative mood, avoidance, and re-
experiencing the trauma that last for a least a month following exposure to a 
stressor (Miao et al. 2018, Kilpatrick et al. 2013, Sareen 2014). Thus, the lifetime 
prevalence of PTSD has been reported to reach ~11% in the general population 
and 25% in the veteran population (Spottswood et al. 2017). PTSD also has a high 
level of impact on the community surrounding the patient, since PTSD is 
associated with difficulty parenting, a reduction in income, and children of patients 
with PTSD exhibit increased levels of impairments in psychosocial behavior (Miao 
et al. 2018, Sareen 2014).  
There are a variety of factors that lead to an increased chance of developing 
PTSD including female sex, having an adverse childhood experience, previous 
drug use, and veteran status (Spottswood et al. 2017, Atwoli et al. 2015, 
Christiansen and Elklit 2008, Carlson et al. 2016, Muller et al. 2017). Women are 
found to not only develop PTSD at more than twice the rate of men (Olff 2017), but 
they develop the disorder at a younger age (Christiansen and Elklit 2008, Smith 
and Cottler 2018). These sex differences observed in PTSD are consistent with 
the hypothesis that there are innate sex differences in brain activity in response to 
stress. Females have been shown to exhibit increased amygdala activation in 




response to negative stimuli and maintain stronger interconnectivity between the 
frontal cortex and the limbic system when compared to men (Helpman et al. 2017). 
Therefore, it is crucial to better understand the extent of the sex differences that 
occur between these types of patients to differentially tailor treatment regimens for 
men and women. 
There are three main neuronal circuits that have been shown to be 
implicated in the initiation of PTSD and, thus, have become targets for the 
treatment of this disorder (Sheynin and Liberzon 2017). First, the fear learning 
circuitry, with a focus on the amygdala and medial prefrontal cortex, has been 
highly implicated in PTSD with the general hypothesis being that alterations in PFC 
signaling results in hyperactivation of the amygdala and exaggerated responses 
to fear stimuli (Markowitz and Fanselow 2020, Sheynin and Liberzon 2017, 
Kelmendi et al. 2016). Additionally, PTSD is associated with irregularities in the 
circuitry that is responsible for context processing including the hippocampus with 
connections to the mPFC that are involved in contextual regulation of fear 
responses (Kelmendi et al. 2016, Sheynin and Liberzon 2017). The third circuit of 
interest includes the emotional regulation pathway from the PFC and amygdala 
that, when impaired following stress exposure, leads to the improper regulation of 
emotions and contributes to PTSD symptoms (Sheynin and Liberzon 2017). The 
only FDA-approved pharmacological treatment for PTSD are selective serotonin 
reuptake inhibitors (SSRIs) while the first line psychological treatment is exposure 
therapy (Kelmendi et al. 2016, Sheynin and Liberzon 2017). Notably, SSRIs do not 




treat stress induced alterations in the three circuits described above and have 
found to be effective as a PTSD treatment in less than 30% of patients (Alexander 
2012, Kelmendi et al. 2016). Recently, further studies have shown that these 
medications to not have any effect in the treatment of PTSD in military veterans 
when compared to placebo (Kelmendi et al. 2016). Additionally, exposure 
therapies have been found to lack efficacy with up to 77% of patients still qualifying 
for PTSD diagnosis, ~50% not reporting any change in their symptom severity, and 
some patients exhibiting a worsening of symptoms following treatment with 
exposure therapy (Markowitz and Fanselow 2020). While exposure-type therapies 
are used with the intention to affect plasticity in these fear-associated circuits, 
these psychotherapies are often not effective in PTSD patients due to impairments 
in the circuitry that allows for extinction learning (Markowitz and Fanselow 2020, 
Kelmendi et al. 2016, Sheynin and Liberzon 2017). Therefore, since our first line 
treatments for PTSD are often ineffective, recent research has focused on 
developing novel treatments to restore normal activity in these circuits to allow for 










Alcohol Use Disorder 
PTSD often does not occur in isolation, with approximately 90% of patients 
with PTSD reporting at least one comorbid psychological disorder (Miao et al. 
2018) with the most prevalent including depression, anxiety, or substance use 
disorder (Sareen 2014, Muller et al. 2017, Carlson et al. 2016). In patients with 
PTSD, alcohol is one of the most commonly used substances to decrease the 
feelings of heightened anxiety and arousal experienced with PTSD symptoms 
(Smith and Cottler 2018). The common occurrence of these symptoms in PTSD 
patients can often lead to alcohol use disorder (AUD), which is recognized when 
drinking reaches a rate of over five drinks per day for males and four for females. 
This disorder is marked by a series of physiological and neurological symptoms 
that are generally a result of the effects of ethanol on cellular toxicity in the brain 
and periphery (Kranzler and Soyka 2020, Wackernah et al. 2014). Alcohol is one 
of the most commonly used illicit substances, and the 12-month prevalence of AUD 
has been recently shown to reach levels as high as 13.9% with lifetime prevalence 
of ~36% (Grant et al. 2017). Importantly, rates of AUD differ between the sexes, 
with males reporting double the rate of AUD when compared to females (Kranzler 
and Soyka 2020).  
While alcohol use disorder alone is one of the most common psychiatric 
disorders, AUD in PTSD patients is observed at rates up to 79% (Pietrzak et al. 
2011). Broadly, there are two main theories regarding the bidirectional relationship 
between comorbid PTSD and AUD with evidence to support both hypotheses. 




First, it has been widely reported that AUD develops following PTSD in accordance 
with the self-medication hypothesis where alcohol is being used to decrease 
anxiety (Smith and Cottler 2018). This hypothesis has been observed in both 
epidemiological research, where a PTSD diagnosis predicts the later development 
of AUD (Breslau et al. 2003), and in clinical studies, where patients with PTSD 
report increased alcohol cravings following the presentation of trauma related cues 
(Coffey et al. 2002). More recently, an alternative hypothesis has been suggested 
under which patients with substance use disorders are more likely to experience a 
traumatic event and, thus, develop PTSD than non-users (Cottler et al. 1992). 
Additional epidemiological studies have also found sex differences in this effect, 
where drug use has been shown to be initiated prior to trauma exposure in males 
but not females (Cottler et al. 2001).  
PTSD and AUD interact in a complex manner to affect cognition and has 
led to the characterization of AUD and PTSD as disorders of learning and memory 
(Hyman 2005; Vanelzakker et al. 2013). As mentioned above, alcohol can be used 
as an anxiolytic by PTSD patients to acutely reduce the intense anxiety 
experienced following PTSD symptoms such as nightmares or re-experiencing the 
trauma. Theoretically, a cycle occurs where alcohol is used to alleviate PTSD 
symptoms but instead renders the fear memory resistant to extinction (Figure 1-
1). This ultimately leads to increased alcohol consumption, the development of 
AUD, and the progression of cognitive deficits that exacerbate these disorders. 
This theory follows the self-medication hypothesis and is further supported by both 




clinical (Kessler et al. 1995; Sundin et al. 2014) and preclinical (Meyer et al. 2013) 
studies. Essentially, chronic and high-volume alcohol intake can affect cognitive 
functioning and worsens PTSD symptoms by interfering with the learning and 
memory processes that are responsible for the extinction of trauma associated 
cues (Back et al. 2006) Therefore, it is important to examine the underlying circuitry 
that overlaps between these two disorders to establish potential targets for the 
















Due to the pervasive effects of alcohol exposure on the brain, the 
neurocircuitry underlying the initiation and maintenance of AUD is widespread. The 
glutamatergic system is highly involved in the reinforcing effects of alcohol through 
downstream activity in key brain regions including the nucleus accumbens and 
amygdala (Gilpin and Koob 2008, Koob and Volkow 2018). Additionally, the PFC 
has been highly studied with regards to addiction due to its functions in executive 
control and ability to modulate dopamine from the reward circuits originating in the 
striatum (Volkow et al. 2011, Koob and Volkow 2018). Glutamatergic signaling at 
both NMDA as well as metabotropic glutamate receptors subtype 5 (mGlu5) is also 
involved in the addiction process due to their role in increasing plasticity throughout 
the brain (Gilpin and Koob 2008). Additionally, alcohol has been shown to have 
effects on glutamatergic signaling throughout neuronal stress systems which leads 
to alterations in both behavioral responses to stressors as well as dysregulation of 
this circuitry (Gilpin and Koob 2008, Volkow et al. 2011, Koob and Volkow 2018).  
While AUD is highly prevalent and one of the leading causes of preventable 
deaths, there is a three-pronged barrier to treating this disorder since there is a 
lack of effective treatments, an extremely low 8.3% rate of treatment seeking, and 
an under prescription of pharmacological treatments (Kranzler and Soyka 2020, 
Ray et al. 2020, Witkiewitz et al. 2019, Swift and Aston 2016). Additionally, the 
symptoms that are experienced during alcohol withdrawal are highly aversive 
including nausea, anxiety, tremors, and life-threatening seizures (Swift and Aston 
2016, Witkiewitz et al. 2019). Currently, there are four pharmaceutical treatments 




approved by the FDA for the treatment of AUD. Generally, the therapeutic 
approach behind these treatments depends on lessening the rewarding properties 
of alcohol use by inducing deleterious side effects as a consequence of alcohol 
use (Swift and Aston 2016). Over time, the pairing of alcohol with these side effects 
leads to an aversive response to alcohol and decreased use (Witkiewitz et al. 
2019, Swift and Aston 2016). Due to the unpleasant nature of these drug 
treatments, adherence and long-term use of these medications are difficult to 
achieve in the AUD population (Swift and Aston 2016). With regards to 
psychological treatments, cue-exposure therapy is often used for the treatment of 
substance use disorders (Ray et al. 2020, Chambless and Ollendick 2001, 
Mellentin et al. 2017). Such treatments rely on the presentation of alcohol-
associates cues and stimuli in the absence of any alcohol reinforcer so that over 
time patients lose their enhanced responses to alcohol related cues (Byrne et al. 
2019, Mellentin et al. 2017, Ray et al. 2020). This method of therapy is theoretically 
sound but does not take into account the fact that patients with AUD have deficits 
in plasticity and cognition as a result of alcohol intake and, therefore, are not able 
to fully respond to cue exposure therapies (Ray et al. 2020, Conklin and Tiffany 
2002). Thus, recent research has been focused on using pharmacological agents 
to enhance cognition and increase the efficacy of cue exposure therapies for the 
treatment of AUD (Ressler et al. 2004, Ray et al. 2020, Vengeliene et al. 2008). 
 
 




Cannabis Use Disorder 
In addition to alcohol, cannabis use is also highly prevalent in patients with 
PTSD (Hasin et al. 2016). As public perception of cannabis remains positive, with 
trends towards legalization growing across the country, cannabis use has been 
steadily rising with rates of drug use at 4.1% in 2002 increasing to 9.5% in 2013 
(Hasin et al. 2015). Not only has cannabis become one of the most commonly 
abused substances, concentrations of delta-9 tetrahydrocannabinol (THC), the 
psychoactive component of the drug, have increased as well. In the 1990’s, the 
concentration of THC in common cannabis strains was ~2%, but more recently 
THC concentration has been recorded to be 17-28% in the most popular strains in 
Colorado dispensaries (Stuyt 2018, Lafaye et al. 2017, Licata et al. 2005). 
Importantly, while the THC concentration has been sharply increasing, the 
cannabidiol (CBD) concentration in cannabis has decreased from 0.5% to 0.09-
0.2% (Stuyt 2018, Lafaye et al. 2017). This is especially concerning considering 
the fact that the determinantal effects of cannabis are directly related to the amount 
of THC while CBD can have a protective effect on the adverse effects of THC 
(Niesink and vanLaar 2013, Lafaye et al. 2017). Chronic use of high-THC cannabis 
has been shown to cause deficits in cognition, increased anxiety and psychosis, 
and a higher chance of developing cannabis use disorder (CUD) (Volkow et al. 
2014, Lafaye et al. 2017, Fergusson and Boden 2008). While 9% of people who 
use cannabis will develop CUD, this rate increases to 25-50% in those who start 
using in adolescence (Volkow et al. 2014). Earlier cannabis use is also associated 




with further adverse effects including comorbid psychiatric disorder, reduced life 
satisfaction, and cognitive impairment (Fergusson and Boden 2008, Rey et al. 
2002), most likely due to ongoing brain development, including the maturation of 
synaptic connectivity and the endocannabinoid system, that continues throughout 
mid- to late-adolescence (Tortoriello et al. 2014, Volkow et al. 2014, Berghuis et 
al. 2007, Keimpema et al 2011).   
While cannabis is one of the most commonly used elicit substances, it has 
only recently been recognized to have the potential to lead to CUD (Brezing and 
Levin 2017, Panlilio and Justinova 2017). Therefore, research dedicated to the 
treatment and reduction of harm in CUD has not been fully examined. Although 
research regarding cannabis use has been growing since the early 2000s, there 
are currently no FDA-approved treatments for CUD (Brezing and Levin 2017). 
While CUD alone is associated with adverse consequences, this disorder is also 
highly comorbid with other substance use and psychiatric disorders that lead to 
further impairments in cognition. Those with CUD have been shown to have up to 
a 10x greater chance of developing AUD and a 6x greater chance of developing 
PTSD than those without CUD (Hasin et al. 2015, Hasin et al. 2016). Additionally, 
there is a bidirectional relationship observed with PTSD and CUD and, in states in 
which cannabis is legalized, up to 38.5% of their users cite PTSD symptoms as 
their reason for obtaining the drug (Yarnell 2015, Mizrachi Zer-Aviv et al. 2016, 
Wilkinson et al. 2015). Additionally, CUD rates are especially high among veterans 
who have developed PTSD following trauma exposure (Khoury et al. 2010). 




Acutely, cannabis can have an anxiolytic effect for PTSD patients, but prolonged 
and frequent cannabis use also leads to an increased risk of developing CUD 
along with impairments in prefrontal cortex reliant cognition. This is observed 
especially in adolescents, where marijuana is the most commonly used illicit 
substance by adolescents with PTSD (Yarnell, 2015), and an adolescent with 
PTSD has a two-fold increase in the likelihood of developing CUD (Bujarski et al., 
2012). While cannabis acutely acts to decrease anxiety, use of this drug is often 
associated with worse symptoms outcomes in patients with PTSD, potentially due 
to long term effects on learning and memory through impairments in the developing 
prefrontal cortex (Wilkinson et al. 2015). While the presence of comorbid CUD, 
AUD, and PTSD is firmly established, there has been a lack of pre-clinical research 
into the underlying brain mechanisms that contribute to the maintenance and 












Animal Models of PTSD, AUD, and CUD 
 While the prevalence of AUD, PTSD, and CUD is extremely high, the 
current therapies and pharmaceutical treatments for these disorders do not often 
have a high rate of efficacy (Kelmendi et al. 2016). Therefore, it is especially 
important to complete preclinical research using translational methods to 
investigate the underlying mechanisms responsible for the initiation and 
maintenance of these disorders. As such, a variety of different animal models have 
been developed to mimic these disorders in rodents. While there are multiple 
appropriate models that could be used to depict AUD and PTSD in rats, the models 
used for these studies were specifically selected due to their ability to longitudinally 
measure changes in fear learning and memory.  
 To employ a valid model of PTSD, it should depend on the same underlying 
neurocircuitry that is involved in fear responses between humans and rodents, 
induce behavioral responses to fear associated cues, and mimics the initiation of 
the disorder following exposure to a pivotal experience that induces extreme levels 
of stress (Flandreau et al. 2017, Goswami et al. 2013). A preclinical model of PTSD 
in rodents should allow for longitudinal studies of symptoms induced by stress 
exposure and require only a short duration of exposure to a stressful event to 
induce PTSD-like symptoms (Siegmund and Wotjack 2006, Goswami et al. 2013). 
A variety of tasks have been developed to induce a PTSD-like phenotype in 
rodents including restraint stress, single prolonged stress, social defeat stress, and 
fear conditioning (Borghans and Homberg 2015, Flandreau and Toth 2018, 




Goswami et al. 2013, Whitaker et al. 2014). While each model has individual 
strengths and weaknesses, fear conditioning is the model that best allows us to 
address the hypotheses involved in these experiments regarding long-term 
relationships between chronic drug exposure and fear related learning and 
memory (Ursano et al. 2007; Borghans et al. 2015; Lissek et al. 2015; Singewald 
et al. 2019; Mahan et al. 2012; Amstadter et al. 2009). Since the establishment of 
conditioning relationships by Pavlov almost one hundred years ago, the ability to 
manipulate cue responses has been largely used to study psychiatric disorders 
preclinically (Pavlov 1927, VanElzakker et al. 2013). Briefly, conditioning studies 
rely on the formation of associations between an unconditioned stimulus (US) 
paired with a conditioned stimulus (CS) where subsequent presentations of the CS 
will allow the originally unconditioned response (UR) to become a conditioned 
response (CR) (Lissek and van Meurs 2014, VanElzakker et al. 2013). This 
premise underlies the method of fear conditioning used to induce behavioral 
phenotypes similar to PTSD, where a tone and footshock serve as the CS and US 
respectively, and the freezing response is the UR that develops into the CR over 
time (Lissek and van Meurs 2014). Thus, we can measure the CR over time during 
both the conditioning, extinction, and recall phases as well as monitor responses 
during these behaviors following chronic drug exposure.  
Fear conditioning was followed by binge-like exposure to alcohol in these 
experiments to translationally model exposure to a discrete trauma followed by 
drug use as self-medication. For our model of AUD, certain aspects of the disorder 




in humans need to be considered, including the level of alcohol consumption, 
alcohol dependence, compulsive alcohol seeking, and relapse behavior (Crabbe 
2014, Helms et al. 2015, Goltseker et al. 2019). While many different drug self-
administration paradigms have been developed that address the seeking and 
relapse aspects of AUD, these protocols will only allow for blood ethanol 
concentrations to reach moderate levels since animals will not drink to excess 
(Augier et al. 2014, Goltseker et al. 2019). Therefore, a more intensive model has 
to be used for studies examining the effects of a high and sustained levels of 
ethanol exposure. As such, many investigators now use the chronic intermittent 
ethanol (CIE) vapor exposure paradigm to model AUD (Ewin et al. 2019; Holmes 
et al. 2012; Sanna et al. 2002; Singewald and Holmes 2019), and it has become 
the standard model used to induce alcohol dependence in rats. Furthermore, 
individuals with AUD often achieve blood ethanol concentrations (BECs) well 
above the legal limit of intoxication similar to the levels achieved in CIE exposure 
which could not be established in rodents with voluntary drinking paradigms alone 
(Becker 2013; Griffin 2014). As such, CIE exposure was used for the experiments 
involved in this dissertation to model the binge-like levels of alcohol exposure 
commonly achieved in patients with AUD.  
In recent years, cannabis use has been more intensively examined in 
preclinical studies. While previously the effects of cannabis have been studied by 
testing the effects of CB1 agonists on the brain, more translational models of 
cannabis exposure have been developed recently as government regulations 




regarding the use of THC have changed (Panlilio and Justinova 2017). An 
additional challenge with modeling cannabis use in animals is that laboratory 
animals would not establish self-administration behavior for THC (Lefever et al. 
2014, Panlilio and Justinova 2017). Recently, a novel and reliable method THC 
self-administration has been established that uses a combination of THC and CBD 
as well as a passive vapor exposure to temper the aversive and anxiogenic 
aspects of THC administration (Spencer et al. 2019). Not only will rats acquire self-
administration behavior using this model, but they achieve the physiological and 
neurological alterations that are often observed as a result of cannabis use 
(Spencer et al. 2019). Therefore, the experiments discussed in this dissertation 
involve this THC vapor administration model to mimic frequent cannabis intake in 
a translationally relevant method. 
In summary, while there are many valid animal models that could be used 
to replicated these disorders in rodents, we incorporated fear conditioning, CIE, 
and THC+CBD vapor exposure as our models of stress, alcohol, and cannabis 
exposure to generally study long-term relationships between stress, alcohol, and 









The Prefrontal Cortex 
 The prefrontal cortex (PFC) is highly involved in both addiction and anxiety 
disorders and, therefore, is the target region of study for these experiments. In 
humans, the PFC makes up one third of the cortex and has complex structural and 
functional organization that allow for its involvement in executive function and top-
down control of behavior (Siddiqui et al. 2008, Abernathy et al. 2013). This region 
is located in the frontal cortex area anterior to the primary motor cortex and 
includes the orbitofrontal, lateral, and medial/cingulate PFC subregions which 
maintain reciprocal connections (Abernathy et al. 2013, Radnikow and Feldmeyer 
2018). The PFC also sustains long-range projections throughout the brain from 
cells across six cortical cell layers (Abernathy et al. 2013). These layers can be 
differentiated through distinct anatomical and cellular features and display layer-
specific gene expression of different cell types and receptors (Radnikow and 
Feldmeyer 2018). While over 80% of the cortex is comprised of glutamatergic cells, 
there is layer specific cellular diversity in terms of morphology and signaling 
properties that allow these layers to serve distinct functions (Song and Moyer 
2018, Little and Carter 2012, Dembrow et al. 2010, Abernathy et al. 2013). For 
example, layer V excitatory pyramidal cells are the primary source of PFC output 
while layers 1 and 2/3 receive and process signals from axons originating across 
a wide range of other brain regions including the thalamus, amygdala, and 
hippocampus (Little and Carter 2012, Dembrow et al. 2010). Additionally, although 
they make up a smaller percentage of total cells throughout this region, inhibitory 




GABA interneurons are found throughout the PFC and serve to modulate signaling 
from the primary pyramidal cells (Abernathy et al. 2013). The diffuse projections 
into and out of the PFC allow for control over a wide range of higher order functions 
including the planning and direction of behavioral output and attention, active 
memory and encoding, and language (Siddiqui et al. 2008, Abernathy et al. 2013). 
The control of these functions is distributed throughout the lateral, orbitofrontal, 
and medial PFC subregions (Siddiqui et al. 2008, Abernathy et al. 2013). 
Generally, the lateral PFC has been shown to be highly involved in the control of 
working memory, attention, and cognitive flexibility (Siddiqui et al. 2008, Abernathy 
et al. 2013, Szczepanski and Knight 2014), while the orbitofrontal region is known 
for its functions in emotional and inhibitory control, decision making regarding 
rewards, and reversal learning (Siddiqui et al. 2008, Abernathy et al. 2013, 
Szczepanski and Knight 2014). While the functions of the lateral and orbitofrontal 
PFC are broadly involved in the circuitry of addiction and anxiety disorders, the 
medial PFC (mPFC) is especially important due to its ability to control fear and 
drug-seeking behaviors (Siddiqui et al. 2008). Additionally, this region has been 
shown to be essential for the exposure-based therapies previously mentioned as 
the first-line psychological therapy for conditions like PTSD and AUD (Groblewski 
and Stafford 2010). Therefore, in this dissertation, the mPFC and its subregions 
are the focus of study due to their established ability to modulate behavioral 
responses to drug and fear cues and involvement in the pathophysiology of 
PTSD/AUD.  




Prelimbic and Infralimbic Subregions 
This dissertation’s focus on mPFC subregions originates from the fact that 
patients with PTSD and AUD exhibit alterations in these regions as a result of 
stress and alcohol exposure (Suh and Ressler 2018). It is important to note that 
mPFC subregions are differentially referenced in humans versus rodents, where 
the human dorsal anterior cingulate cortex (dACC) is a correlate of the rodent 
prelimbic cortex (PrL) while the human ventro-medial PFC is the infralimbic cortex 
(IfL) in the rodent (Milad and Quirk 2012). Generally, the PrL region has been 
shown to function in the promotion of fear behaviors while the IfL is involved in 
extinction learning by reducing responses to fear stimuli (Milad and Quirk 2012, 
Peters et al. 2009). There is a wide range of studies that investigate the PrL that 
demonstrate its ability to control responses to fear cues, including signaling studies 
where the PrL exhibits increased activity in response to fear cues (Burgos-Robles 
et al. 2009) and activation studies where PrL activation or inactivation increases or 
decreases the expression of conditioned fear behaviors respectively (Laurent and 
Westbrook 2009, Sierra-Mercado et al. 2006, Sierra-Mercado et al. 2011, 
Corcoran and Quirk 2007, Vidal-Gonzalez et al. 2006). Additional studies have 
shown that there is conditioning induced plasticity exhibited in the PrL (Burgos-
Robles et al. 2007, Corcoran and Quirk 2007, Mahan and Ressler 2012, Song et 
al. 2015) and time-course studies determine that activity in the PrL mirrors the 
freezing activity of the animal during conditioning (Gilmartin and Helmstetter 2010, 
Milad and Quirk 2016, Burgos-Robles et al. 2009). The PrL has also been shown 




to be highly involved in the top-down control of drug-seeking behaviors (Lasseter 
et al. 2010). The contributions of the PrL to drug seeking behavior has been shown 
with regards to a wide variety of drugs of abuse including cocaine (Cornish and 
Kalivas 2000, McFarland et al. 2003, West et al. 2015), MDMA (Ball and Slane 
2012), heroin (LaLumiere and Kalivas 2008, Lasseter et al. 2010), and alcohol 
(Palombo et al. 2017, Kroener et al. 2012). These studies highlight the fact that the 
PrL is especially important in both the acquisition of drug seeking behavior as well 
as cue-induced relapse (Lasseter et al. 2010). Additionally, this function of the PrL 
has been shown to involve glutamatergic signaling from this region to the nucleus 
accumbens core (NAc), since inactivation of this pathway prevents relapse like 
behavior (LaLumiere and Kalivas 2008). Thus, due to the highly overlapping role 
of the PrL in both fear expression and promotion of drug seeking behavior, this 
region is an important target of study regarding comorbid PTSD and SUD.  
Alternately, the IfL has been shown to be involved in opposing the PrL to 
allow for reduced responses to fear stimuli by controlling extinction learning (Milad 
and Quirk 2016). Initial lesion studies showed that the loss of IfL activity leads to 
an inability to retrieve extinction memories (Quirk et al. 2000) while recording 
studies demonstrate that IfL signaling is involved during extinction retrieval (Milad 
and Quirk 2002), and stimulation of this region reduces the expression of fear 
behaviors (Herry and Garcia 2002, Milad and Quirk 2002). Specifically, it has been 
shown that extinction memories rely on NMDA activation in the IfL (Burgos-Robles 
et al. 2007, Chang et al. 2010) and increased plasticity in this region is required to 




express extinction behavior (Santini et al. 2008). Parallel to its function in the 
extinction of fear behaviors, the IfL is also highly involved in the extinction of drug-
seeking behaviors. IfL projections to the nucleus accumbens shell (NAs) have 
been shown to be involved in the suppression of drug seeking behavior (Peters et 
al. 2009), stimulation of the IfL has the ability to reduce relapse in reinstatement 
tests, and inactivation of the IfL following extinction allows for a return to drug 
seeking behavior (Ovari and Leri 2008, Peters et al. 2008). Therefore, as a pivotal 
region for the control of extinction of fear and drug-seeking behaviors, the IfL is an 
important region to study in terms of the treatment of comorbid PTSD/SUD.  
 
Downstream Signaling Targets 
 There are a wide variety of downstream regions to which the PrL and IfL 
signal to control the expression and suppression of fear and drug-seeking 
behaviors (Figure 1-2) (Peters et al. 2009). With regards to the expression of fear 
behavior, the PrL is known to signal to multiple subregions of the amygdala through 
excitatory glutamatergic projections (Peters et al. 2009, Brinley-Reed et al. 1995, 
Vertes 2004, Gabbott et al. 2005). The basolateral amygdala (BLA) is one of the 
primary sites of projection from the PrL to control the expression of conditioned 
fear behavior (Anglada-Figueroa and Quirk 2005, Herry et al. 2008). Additionally, 
there are multiple internal signaling pathways within the amygdala from the lateral 
amygdala, the main area responsible for the storage of fear memories, and the 
central amygdala, the main source of output from the amygdala, to allow for 




increased amygdala output to downstream regions such as the brainstem and 
hypothalamus to increase the presentation of the physiological and behavioral fear 
responses (Blair et al. 2001, Repa et al. 2001, Wilensky et al. 2006, Zimmerman 
et al. 2007). Alternatively, the IfL also sends glutamatergic projections to the 
amygdala, but instead targets the GABA interneurons in the intercalated cell region 
of the amygdala that allow for a reduction of activity from the central amygdala 
(Berretta et al. 2005, Peters et al. 2009, Jüngling et al. 2008, Likhtik et al 2008). 
These amygdala subregions have also been shown to exhibit NMDA-dependent 
plasticity as a result of sustained IfL activity during extinction learning (Royer and 
Pare 2002). Additionally, these regions have differential projections to the nucleus 
accumbens to control addiction related behaviors (Peters et al. 2009). The PrL is 
known to signal to the NAc and studies have shown that increased glutamate 
release in this pathway can serve as a trigger for the relapse of drug seeking 
behavior (Voorn et al. 2004, McFarland et al. 2003, LaLumiere and Kalivas 2008). 
Alternatively, the IfL projections to the NAs are responsible for extinction of drug 
seeking behaviors shown the correlation of increased glutamatergic plasticity in 
this region with extinction behavior as well as inactivation of this circuitry leading 
to a return of conditioned drug seeking (Peters et al. 2008, Peters et al. 2009, 
Sutton et al. 2003). These regions have been shown to be clinically relevant in 
disorders such as PTSD and AUD, where these patients exhibit extinction learning 
deficits and hyperactivity in response to fear and drug related cues due to 
alterations in these regions (Phelps et al. 2004, Milad et al. 2007, Milad et al. 2008, 
Garavan et al. 2000, Coffey et al. 2002). Thus, while this dissertation focuses on 




the contribution of the PrL and IfL to fear- and drug-related behaviors, these 
downstream regions are further targets of interest that could be involved in the 




Effects of THC, Ethanol, and Stress on PFC Glutamate Function  
Since the PrL and IfL have been shown to be extensively involved in the 
control of fear and drug-seeking behaviors, it is important to examine how these 
regions are affected by stress and drug exposure to cause the disordered 
behavioral responses found in PTSD/SUD (McEwen and Gianaros 2011). Both 
acute and chronic stress exposure has been shown to affect glutamatergic 
transmission in the prefrontal cortex, and therefore cognitive functioning, through 




increased glucocorticoid release that occurs following stress exposure (Popoli et 
al. 2011, Liston et al. 2006). The major glucocorticoid in rodents, corticosterone 
(CORT), has been shown to affect baseline glutamate release in the PFC and 
acute stress exposure or CORT administration will cause a rapid increase in 
glutamate in this region (Karst et al. 2005). Similarly, exposure to chronic stressors 
will cause long-term increases in glutamate in the PFC (Moghaddam 1993, Bagley 
and Moghaddam 1997). These alterations in glutamate signaling due to stress 
exposure will also cause detrimental changes in plasticity in the PFC to amygdala 
pathway that lead to lasting changes in behavioral responses to stress (Musazzi 
et al. 2015). Additionally, drastic increases in glutamate as a result of stress 
exposure can lead to excitotoxicity and cell death in the PFC which further impairs 
cognitive function (Popoli et al. 2011).  
Alcohol has the ability to affect a wide variety of receptors throughout the 
brain to cause pervasive effects on neural function (Abernathy et al. 2010). In the 
prefrontal cortex, alcohol has been shown to affect glutamate signaling following 
both acute and long-term exposure (Abernathy et al. 2010, Burnett et al. 2015). 
Additionally, the severity of alcohol dependence has been corelated with glutamate 
levels recorded in cerebrospinal fluid in humans (Umhau et al. 2010). Alterations 
in glutamate signaling due to prolonged alcohol exposure have also been shown 
to be associated with deficits in cognitive functioning that can last even following 
prolonged abstinence periods of over a year (Burnett et al. 2015, Stavro et al. 
2013) and the degree of cognitive impairments is correlated with an increased risk 




for relapse (Abbott and Gregson 1981, Bowden-Jones et al. 2005). These alcohol 
dependent cognitive deficits have been shown to be a result of maladaptive 
changes in glutamate function in the PFC as a result of alcohol exposure (Burnett 
et al. 2015, Chandler et al. 1993, Qiang et al. 2007, Kroener et al. 2012). Often, 
these neuroadaptations lead to impairments in behaviors such as impulse control 
and cognitive flexibility, which lead to deficits in top down control and contribute to 
compulsive and high-volume alcohol consumption (Burnett et al. 2015, Kroener et 
al. 2012). 
In addition to the glutamatergic alterations induced by stress and alcohol 
exposure, cannabis has also been shown to affect this system in the PFC 
especially when used during adolescence (Cass et al. 2014, Renard et al. 2017, 
Schneider et al. 2008). The PFC is highly remodeled during adolescence, including 
endocannabinoid and CB1 mediated synaptic pruning to maintain the 
excitatory/inhibitory signaling balance (Renard et al. 2017, Caballero et al. 2014, 
Thomases et al. 2013). Thus, if CB1 activity is altered through external sources, 
such as cannabis, this refinement process can be disrupted leading to long-term 
changes in excitatory signaling in the PFC as a result of cannabis exposure (Cass 
et al. 2014). Essentially, increased CB1 activity during the adolescent phase of 
development impairs the maturation of GABA synapses and subsequently allows 
for a hyperactivity of the glutamate synapses in the PFC (Cass et al. 2014, Renard 
et al. 2017). Therefore, cannabis use during adolescence could have long-term 




effects on behaviors that depend on the PFC including responses to stress and 
drug cues (Meier et al. 2012, Solowij et al. 2002, O’Shea et al. 2004).  
 
Glutamatergic Modulators as PTSD/SUD Treatment 
The glutamate system in the PFC has increasingly become a treatment 
target for PTSD/SUD due to the high level of involvement of glutamatergic 
functioning in this region in the disordered behavioral regulation found with these 
disorders. A variety of glutamatergic modulators that target both ionotropic NMDA 
receptors as well as metabotropic mGlu5 receptors have been studied as a 
treatment for both PTSD and AUD (Averill et al. 2017). Ketamine, an NMDA 
antagonist, has recently been explored as a treatment for PTSD and has been 
shown to cause significant reductions in the severity of PTSD symptoms when 
compared to midazolam, an anxiolytic medication commonly used to treat PTSD 
related anxiety (D’Andrea and Sewell 2013, Feder et al. 2014). Additional 
therapeutics include d-cycloserine (DCS), a partial agonist at NMDA receptors, 
which has been used clinically with variable effects (Difede et al. 2013, Attari et al. 
2014). DCS has been used as an adjunct to psychological treatments, including 
exposure therapy, to modulate NMDA receptors and plasticity to improve extinction 
learning (Averill et al. 2017, Norberg et al. 2008). Similarly, glutamatergic 
modulators have been used in the treatment of addictive disorders (Joffe et al. 
2018). DCS has also been used for its effects on drug-seeking and has been 
shown to facilitate the extinction of this behavior (Botreau et al. 2006). Along with 




targeting glutamate receptors to enhance extinction and treat AUD, 
pharmacotherapies have been used to target glutamate reuptake at glutamate 
transporter 1 (GLT1) to decrease the glutamate spillover often associated with this 
disorder (Rao et al. 2015). Specifically, ceftriaxone has been used to increase 
GLT1 and has been shown to decrease ethanol consumption as well as attenuate 
withdrawal and relapse (Rothstein et al. 2005, Rao and Sari 2012, Sari et al. 2011). 
Therefore, due to the role of glutamate in mediating the symptomology of PTSD 
and AUD, the studies completed in this dissertation use glutamatergic modulators 
to alter the effects of stress and drug exposure on prefrontal cortex reliant signaling 
and cognition.  
 One pharmacotherapy used for these studies is CDPPB (3-cyano-N-(1,3-
diphenyl-1H-pyrazol-5-yl) benzamide). CDPPB is a positive allosteric modulator of 
mGlu5 receptors that has been shown to affect glutamate signaling in the PFC and 
behavioral responses to fear and drug related learning paradigms following drug 
exposure in preclinical models of PTSD and AUD (Gass et al. 2018, Smiley et al. 
2020). Specifically, CDPPB has been shown to enhance the extinction of cocaine 
and ethanol seeking behaviors, and these behavioral changes are associated with 
enhanced plasticity in the mPFC (Gass and Olive 2009, Cleva et al. 2011, Gass et 
al. 2018). In these studies, the effects of CDPPB were shown to be mGlu5 
dependent, since infusions of an mGlu5 antagonist into the mPFC prevented the 
effects of CDPPB on the extinction of alcohol seeking behavior (Gass et al. 2014). 
Thus, due to the highly overlapping underlying circuitry responsible for drug 




seeking and fear expression, further studies covered under this dissertation utilized 
CDPPBs ability to enhance extinction by targeting fear extinction learning.  
 N-acetylcysteine (NAC) is a clinically available therapeutic that has recently 
become a popular treatment for a variety of psychological disorders, including 
PTSD and AUD, due to its ability to affect glutamate homeostasis in the brain 
(Reissner and Kalivas 2010). Both clinically and preclinically, NAC has been 
shown to affect drug seeking behavior, clinically through a reduction in drug use 
when administered to veterans with comorbid PTSD/SUD (Back et al. 2017) and 
preclinically by reducing stress-cue induced relapse in alcohol self-administration 
models (Garcia-Keller et al. 2019). Preclinical studies have also sought to 
determine the method through which NAC is exerting these effects. Both stress 
and alcohol exposure have been shown to alter the levels of GLT1 and NAC has 
been shown to restore GLT1 levels while reducing drug seeking behaviors (Kalivas 
and Volkow 2011, Brown et al. 2013). Therefore, due to its ability to normalize 
glutamatergic functioning in the brain and effects on treating the deleterious effects 
of stress exposure and drug exposure, NAC is a promising candidate for the 
treatment of co-morbid PTSD/AUD and needs to be further tested in animal models 









 PTSD and SUD are disorders of learning and memory that involve deficits 
in overlapping circuitry in the prefrontal cortex. These disorders often occur 
comorbidly due to the anxiolytic properties of drugs such as cannabis and alcohol. 
While acutely these substances will decrease the feeling of anxiety, they also lead 
to long term alterations in prefrontal glutamate function that can cause a 
progression of cognitive deficits that impair the effectiveness of pharmacological 
and psychological treatments of PTSD. Therefore, it is increasingly important to 
study the prefrontal cortex to determine how stress and drug exposure are 
affecting this region and to determine glutamate functioning in this region could 
serve as a target for the treatment of PTSD altered by substance abuse.  
 
Statement of Problem and Specific Aims 
 Post-traumatic stress disorder and comorbid substance use disorder is a 
highly prevalent and debilitating reality for many patients. As a result of stress and 
drug exposure, there are a variety of deleterious effects on the prefrontal cortex in 
terms of signaling and activity as well as behavioral and cognitive consequences. 
This is reflected in both clinical and preclinical studies that demonstrate that the 
presence of both PTSD and SUD result in worst symptomology as well as 
decreased efficacy of both pharmacological and psychological treatment options. 
Therefore, it is increasingly important to examine the bidirectional relationship 




between stress exposure and drug use to determine optimal targets for treatment. 
The experiments presented within this dissertation use fear conditioning as well as 
chronic intermittent ethanol exposure and THC vapor exposure to model PTSD, 
alcohol use, and cannabis use to answer questions regarding the effects of drug 
exposure on fear learning as well as the effects of stress exposure on drug intake. 
The overall hypothesis for these studies is that exposure to THC and ethanol alters 
signaling in the prefrontal cortex to affect fear learning and memory and that, 
conversely, stress exposure escalates responses to drug related cues through a 
similar mechanism. The following aims were designed to test this hypothesis.  
 
SPECIFIC AIM 1: TEST THE HYPOTHESIS THAT STRESS EXPOSURE CAUSES ALTERATIONS 
IN ETHANOL SEEKING AND COGNITION THAT CAN BE PREVENTED WITH N-
ACETYLCYSTEINE. 
Following exposure to a traumatic event, patients that develop PTSD often 
use substances like alcohol to self-medicate symptoms of anxiety that are often 
experienced when exposed to trauma-related cues. Additionally, these patients 
experience the development of cognitive deficits that impairs the effectiveness of 
psychological treatment options and worsens symptomology. Therefore, to study 
this relationship in preclinical models, we used a model of PTSD/AUD using 
restraint stress followed by ethanol self-administration to see how prior exposure 
to stress effects ethanol seeking during acquisition and reinstatement. Further, 
animals were tested in a strategy set-shifting task to assess how stress exposure 




affects cognition. Finally, we tested N-acetylcysteine in a variety of different 
treatment schedules to optimize the use of this drug for the prevention of stress-
induced alterations in ethanol seeking and cognition.  
 
SPECIFIC AIM 2: TEST THE HYPOTHESIS THAT CHRONIC ETHANOL EXPOSURE IMPAIRS 
FEAR LEARNING THROUGH PREFRONTAL GLUTAMATERGIC MODULATION. 
Due to the bidirectional relationship between stress exposure and alcohol 
abuse, we next wanted to test the effects of chronic ethanol on fear learning using 
an alternate model of PTSD/AUD using fear conditioning and chronic intermittent 
ethanol exposure (CIE). First, we tested the effects of CIE on fear extinction 
learning and responding during recall testing and then used CDPPB to enhance 
extinction learning in these animals. Microinjection experiments were then 
completed to determine the neuronal localization of both CIE and CDPPB’s effects 
on extinction learning by implanting canulae into either the prelimbic (PrL) or 
infralimbic cortex (IfL). Next, we wanted to further investigate the relationship 
between chronic ethanol exposure and fear learning by using optogenetics in this 
PTSD/AUD model to inhibit either the PrL or IfL during fear memory 
reconsolidation to alter fear extinction learning.  
 




SPECIFIC AIM 3: TEST THE HYPOTHESIS THAT THC INTERACTS WITH ETHANOL AND 
STRESS TO INDUCE FURTHER COGNITIVE DEFICITS DUE TO IMPAIRMENTS IN PREFRONTAL 
CORTEX GLUTAMATERGIC FUNCTIONING. 
Along with alcohol, cannabis is the most highly abused substance by PTSD 
patients to acutely reduce anxiety. Additionally, there is an inverse relationship 
where cannabis abuse is associated with a higher chance of developing PTSD and 
AUD in the future. As such, we then wanted to determine how THC and ethanol 
exposure interact to cause deficits in prefrontal cortex reliant behavioral paradigms 
including cognitive flexibly, drug seeking, and responses to fear stimuli. Vapor 
exposure to both THC and ethanol was followed by testing in strategy set-shifting 
procedures, ethanol self-administration, and fear conditioning paradigms to assess 
how drug exposure affects behavioral responses to these mPFC dependent tasks. 
Further, calcium imaging through fiber photometry was used to assess the activity 















N-ACETYLCYSTEINE PREVENTS STRESS INDUCED 





Background and Significance 
Post-traumatic stress disorder (PTSD) and alcohol use disorder (AUD) are 
two psychiatric disorders that have become increasingly prevalent and debilitating 
in terms of symptomology and cost to society (Smith and Cottler 2018). Not only 
do these conditions cause a variety of incapacitating symptoms, but they often 
occur co-morbidly with even worse symptoms and treatment outcomes (Dworkin 
et al. 2018; Petrakis et al. 2017). Some of the most common PTSD symptoms 
include re-experiencing the trauma through events like flashbacks and nightmares 




that are induced following exposure to cues that are reminiscent of the original 
trauma event (Ralevski et al. 2014). In both preclinical and clinical research, it has 
been shown that exposure to chronic ethanol can cause deficits in fear cue 
extinction learning and memory which can further fear cue associations and allow 
for continued maladaptive cue responding in PTSD patients that also have AUD 
(Nosen et al. 2015; Vujanovic et al. 2019). Additionally, there are few methods of 
treatment available for these disorders and they are often not effective (Flanagan 
et al. 2018). Thus, there is a need for further research into the establishment and 
maintenance of these disorders to develop pharmacological treatment options for 
comorbid PTSD and AUD.  
Recent studies have focused on the glutamate system as a target for 
treatment of both addictive (Kalivas and Volkow et al. 2011; Gass and Olive 2007) 
and anxiety disorders (Averill et al. 2017; Petrakis et al. 2017) as well as their 
comorbidity (Verplaetse et al. 2018; Smiley et al. 2020). Exposure to both trauma 
and drugs of abuse can have long term effects on plasticity and homeostasis that 
can lead to dysregulation of fear and alcohol seeking behaviors in the future (Averill 
et al. 2017; Rao et al. 2015; Hwa et al. 2017, Gonzales et al. 1997). In addition to 
glutamatergic modulators such as ketamine and D-cycloserine, N-acetylcysteine 
(NAC) has become a popular therapeutic to target this dysregulated plasticity to 
treat PTSD and AUD (Averill et al. 2017; Tomoko et al. 2018; McClure et al. 2014; 
Flanagan et al. 2016). NAC has been used in recent studies that examined the 
effect of NAC on PTSD and SUD symptoms in veterans, and NAC treated patients 




reported significant improvements in both drug craving as well as PTSD symptoms 
compared to placebo (Back et al. 2016). 
Thus, the present experiments examined this relationship in animal models 
using restraint stress followed by alcohol self-administration to mimic a discrete 
stressor event followed by compulsive alcohol use. NAC was used to reduce stress 
cue-induced reinstatement of alcohol seeking, which serves as a preclinical model 
of trauma cue exposure induced relapse. These experiments found that exposure 
to acute restraint stress contributed to increased alcohol seeking during 
acquisition, extinction, and reinstatement and that NAC treatment administered 
either before, after, or surrounding the stressor was able to prevent this increased 
drug seeking. 
 
Materials and Methods 
Animals  
Male Wistar rats (PD 52, 250 g on arrival; Charles River Laboratories, 
Raleigh, North Carolina) were double housed and habituated to a reverse 
light/dark cycle with lights off at 9 a.m. Food and water was available ad libitum 
throughout all experiments, except for during behavioral testing (~1-2 hours per 
day). Animals had 1 week of acclimation in the colony before any testing or 
treatment commenced. All experiments were approved by the Animal Care and 
Use Committee of the Medical University of South Carolina and were in 




accordance with guidelines set forth by the National Research Council’s Guideline 
for the Care and Use of Mammals in Neuroscience and Behavioral Research 
(2003). A total of 120 animals were used across four main experiments and were 




Acute Restraint Stress  
Animals were exposed to an acute stressor in the form of a 2-hour restraint 
stress exposure session. Each animal was placed into a flat-bottomed Plexiglas 
restrainer measuring 3.25 inches in diameter and 8 inches in length and placed 
into a new clean cage for the duration of the test. A conical tube cap containing 3 
mL of an essential oil was included within each of the cages to be used as a stress-
related cue in further testing. For Experiment 1, a crossover design was used with 
regards to stress-paired odor cues where half of the rats were exposed to a 
sandalwood scent while the other half received lemon odor exposure while 
restrained. Following Experiment 1, which showed that responding was specific to 




the stress paired and not the unpaired-odor cue, all animals were exposed to 
sandalwood odor in further experiments. Sham animals were transferred to new 
cages and kept there for two hours in the presence of the odor but were not 
restrained. Animals were monitored for differences in body weight and coat texture 
in the following weeks to ensure that the stress exposed animals did not differ from 
sham animals with regards to heath.  
 
Alcohol Self-Administration 
Prior to operant training, all animals were exposed to a two-bottle choice 
paradigm that involved a bottle of 20% ethanol along with a bottle containing water 
placed on the home cage for three days per week for two weeks to familiarize 
animals with the sensory aspects of the drug. Two days following the last two-
bottle choice session, animals were placed into operant chambers and trained to 
lever press for 20% ethanol on an FR-1 schedule of reinforcement based on our 
previously published methods (Gass 2014a). Sessions occurred three times per 
week and lasted for one hour with each press on the active lever delivering 20% 
ethanol in water for 1.5 seconds with the stimulus light illuminated and a tone 
presented (2900 Hz, 65 dB). Each active lever press was followed by a 4 second 
timeout during which presses were recorded but did not lead to reinforcer delivery. 
Once response criteria of 30 lever presses was met (~8-10 sessions), ethanol 
concentration was lowered to 10% and criteria of 60 lever presses was met (~12 
sessions). Animals completed extinction training once self-administration behavior 




was established (~20 sessions),. During extinction sessions, pressing on the active 
lever occurred in the absence of any light/tone cues or ethanol reinforcer. 
Extinction criteria was met when lever pressing for each rat was below 20% the 
rate of lever pressing recorded on the last two days of self-administration training 
(~8 sessions).  
 
Stress Cue-Induced Reinstatement 
Animals were put into reinstatement testing following the extinction of lever 
pressing behavior. During each 30-minute session, lever presses were recorded 
but did not result in light/tone presentation or ethanol delivery. Two reinstatement 
tests occurred, one in the presence of the stress paired odor and the second in the 
presence of the non-paired order. Using a random crossover design, half of the 
animals received their paired odor first while the other half received the non-stress 
paired odor during the first reinstatement test. Each reinstatement test was 
separated by two subsequent extinction sessions to reduce lever pressing prior to 
the second reinstatement test. Experiment 1 established that reinstatement effects 
were specific to the stress paired odor and, therefore, all following experiments 
used sandalwood odor as the stress paired cue and, thus, only required a single 
reinstatement test (experimental design shown in Figure 2-1).  
 






NAC Administration and Schedules 
For all experiments, NAC was administered at a dose of 100 mg/kg and was 
prepared the day of injection in 27 mg/mL NaOH in saline and pH was adjusted to 
7.2. Vehicle of 0.9% saline was administered to all other animals and injections 
were delivered intraperitonially (IP). A variety of different injection schedules were 
tested to optimize the timeline of treatment and the effects on the glutamate 
system. For Experiment 1, NAC was administered for 4 days prior to and on the 
day of reinstatement testing. Experiment 2 involved NAC treatment for 4 days prior 
to, the day of, and four days following the restraint stress exposure session, while 
Experiment 3 included treatment groups that received either NAC for 4 days prior 
to the stressor or for 4 days following the stressor (Figure 2-2). 
 






Set-Shifting Analysis of Behavioral Flexibility 
A between-session strategy set-shift test was used to assess the effects of 
stress and NAC exposure on learning, behavioral flexibility was examined using 
(Figure 2-3). A separate group of 24 animals were trained to press both the right 
and left levers to receive 10% sucrose followed by retractable lever training and 
determination of a side preference. Animals were then trained under a first rule 
which required animals to respond to the lever that was cued by illumination of the 
associated stimulus light and criteria for this rule was met when animals pressed 
8 times in a row correctly in a minimum of 30 trials. Once this criterion was met, 
animals were tested in a single session under a second rule that required animals 
to press on a single lever location regardless of where the light appears. Animals 
that take longer to learn the second rule and continue responding for the original 
rule are considered to have impaired behavioral flexibility. We also recorded the 
type of errors that animals were making during this trial, mainly perseverative 




errors which are presses on the incorrect lever before the animal has made five 





All analyses were performed using Prism version 8.0 (GraphPad Inc). 
Power analyses were completed to determine optimal group sizes with a 
significance level of p < 0.05. For single comparisons, analyses used a two-tailed 
Student’s t-test while multiple comparisons were completed using two-way 
ANOVAs. Repeated measures ANOVAs were used for within subject 
comparisons. A Bonferroni post-hoc analysis was performed if the interactions 









Exposure to acute restraint stress leads to increases in ethanol seeking  
First, we determined the long-term effects of a single acute restraint stress 
exposure on ethanol seeking behavior during self-administration, extinction, and 
stress-cue induced reinstatement (Figure 2-1). Animals were exposed to a 2-hour 
restraint stress or sham stress in the presence of either a lemon or sandalwood 
scent to serve as a conditioned odor cue during later phases of training. Following 
stress exposure, all animals underwent 2 weeks of two bottle choice for 20% 
ethanol before being trained in operant self-administration followed by extinction. 
There was no difference between stress and sham animals during two-bottle 
choice (Figure 2-4A) or during the first 10 sessions of ethanol self-administration 
where animals were still learning ethanol seeking behavior (Figure 2-4B).  
 




Animals that were previously exposed to restraint stress exhibited 
increased ethanol seeking during self-administration following acquisition. These 
animals increased lever pressing when compared to sham animals during the last 
ten self-administration sessions (Figure 2-5A, two-way RM-ANOVA time F(5, 115) 
= 69.97, p < 0.001, stress vs. sham F(1,22) = 68.54, p < 0.001, interaction F(9,198 
= 5.803, p < 0.001). Additionally, stress exposed animals also sought more ethanol 
reinforcers during these sessions when compared to sham animals (Figure 2-5B, 
two-way RM-ANOVA time F(5,115) = 80.64, p < 0.001, stress vs. sham F(1,22) = 
58.38, p < 0.001, interaction F(9,198) = 5.512, p < 0.005).  This stress-induced 
increase in ethanol seeking was also present when examining at the total number 
of reinforcers received across the entirety of self-administration (Figure 2-5C, two-
way ANOVA stress vs. sham F(1,20) = 347.7, p < 0.001). Following self-
administration, animals were exposed to 8 extinction sessions and stress exposed 
animals exhibited increased lever pressing during this phase of training as well 
(Figure 2-5D, two-way RM-ANOVA time F(5,105) = 8.35, p < 0.001, stress vs. 
sham F(1,22) = 70.83, p < 0.001, interaction F(9,198) = 8.35, p < 0.001).  












Escalations in ethanol seeking during reinstatement following stress exposure are 
prevented with NAC treatment   
Following the extinction of lever pressing behavior, animals were tested for 
reinstatement of alcohol seeking behavior. For 4 days prior to and on the day of 
the reinstatement test, animals were administered I.P injections of either 100 
mg/kg NAC or Vehicle (0.9% saline). Rats within each exposure group were evenly 
distributed into NAC and Vehicle treatment groups so that animals did not differ in 
ethanol seeking behavior prior to treatment (two-way ANOVA NAC vs. Veh F(1,20) 
= 0.57, p = 0.46). Stress exposed animals exhibited increased lever pressing in 
response to the stress paired odor cue during reinstatement when compared to 
sham animals, and NAC treatment prior to reinstatement resulted in a decrease in 
active lever presses when compared to stressed animals that received vehicle 
(Figure 2-6A, three way RM-ANOVA Ext vs. Rst F(1,20), 56.78, p < 0.001, stress 
vs. sham F(1,20) = 55.33, p < 0.001, NAC vs. Vehicle F(1,20) = 47.57, p < 0.0001, 
interaction F(1,20) = 82.07, p < 0.001). There were no differences in lever pressing 
behavior between any of the treatment groups when examining reinstatement 
sessions completed in the presence of the odor that was not paired with the 
stressor (Figure 2-6B, three-way RM-ANOVA Ext vs. Rst F(1,20) = 2.32, p =0.144, 
sham vs. stress F(1,20) = 0.35, p = 0.559, NAC vs. Vehicle F(1,20) = 0.55, p = 
0.466, interaction F(1,20) = 0.69, p = 0.416) or in inactive lever presses during the 
stress paired (Figure 2-6C) and unpaired odor (Figure 2-6D) reinstatement 
sessions.  












NAC treatment surrounding, prior to, and following the stressor all served as 
effective treatments 
Since NAC can have differential effects on the glutamate system depending 
on the timing of treatment, two additional experiments were completed to 
determine the treatment schedule that was the most effective at reducing 
responding during reinstatement (Figure 2-2). The first experiment involved NAC 
administration for 4 days prior to, on the day of, and for 4 days following the 
stressor to prevent stress induced changes in glutamatergic functioning. There 
were no differences found between any groups in terms of ethanol consumption 
during 2-bottle choice (Figure 2-7A) or the first ten sessions of self-administration 
(Figure 2-7B). Once animals acquired self-administration behavior, stress 
exposed animals exhibited an increase in active lever pressing compared to both 
sham exposed animals and those that had been exposed to restraint stress and 
treated with NAC surrounding the stressor (Figure 2-7C, two-way RM-ANOVA 
NAC vs. Vehicle F(3,28) = 13.72, p < 0.001, time F(9,52) = 248.9, p < 0.001, 
interaction F(27,252) = 2.575, p < 0.001). This increase in ethanol seeking was 
also reflected by an increased number of reinforcers received across the entirety 
of self-administration training by stress exposed animals when compared to Sham 
+ Veh and Sham + NAC animals as well as stress exposed animals that were 
treated with NAC (Figure 2-7D, one-way ANOVA F(3,28) = 226.7 p < 0.001). 
 






Following self-administration, lever pressing behavior was extinguished 
before animals were put into stress cue-paired reinstatement testing. Again, stress 
exposure served to increase active lever pressing during reinstatement in the 
presence of the stress paired odor, while NAC treatment administered surrounding 
the stressor was able to prevent this heightened ethanol seeking (Figure 2-8A). 




Additionally, there was no differences between any treatment groups in inactive 
lever pressing during this reinstatement session (Figure 2-8B). Taken together, 
these data suggest that NAC treatment surrounding a stressor is effective at 




Once NAC was established as an effective treatment when administered 
surrounding the stressor, our next experiment was designed to further narrow 
down the necessary treatment regimen for NAC. Two different NAC administration 
schedules were implemented to determine if NAC treatment either prior to or 




following restraint stress was able to prevent stress induced escalations in ethanol 
seeking during self-administration and reinstatement. As such, NAC was 
administered for either 4 days before stress and the day of stress or for 5 days 
after the stress occurred (Figure 2-2). Again, there were no changes in ethanol 
seeking during either 2-bottle choice (Figure 2-9A) or the first ten sessions of self-
administration (Figure 2-9B). Additionally, we were able to replicate the ability of 
stress exposure to increase lever pressing during self-administration and NAC 
treatment both prior to or following the stressor were effective at preventing 
increased ethanol seeking (Figure 2-9C, two-way RM ANOVA treatment F(4,350), 
P < 0.0001, time F(9,350) = 179, p < 0.001, interaction F(36,350) = 1.83, p < 
0.001). This effect was also reflected in the increased number of reinforcers sought 
by stress exposed animals that was prevented with NAC treatment either before 
or after the stressor (Figure 2-9D, one-way ANOVA F(4,35) = 231.2, p < 0.001).  
 






Following the extinction of lever pressing behavior, animals were tested in 
stress-cue induced reinstatement. During this session, animals that were 
previously exposed to restraint stress exhibited increased lever pressing behavior 
when compared to all other groups, and animals administered NAC either prior to 
or following the stressor did not exhibit this relapse-like behavior (Figure 2-10A, 
two-way RM-ANOVA Ext vs. Rst F(1,35) = 57.42, p < 0.0001, treatment F(4,35) = 




28.37, p < 0.0001, interaction F(4,35) = 29.28, p < 0.0001). This behavior was 
specific to active lever presses, since there were no differences between any 




Stress exposure causes deficits in behavioral flexibility that are prevented with 
NAC 
An operant set-shifting task was used to determine if stress exposure or 
NAC treatment had any effects on operant learning. NAC (100 mg/kg) or vehicle 
was delivered for 4 days before, on the day of, and for 4 days following the stressor 
and set-shifting training commenced the following week (Figure 2-3). Once 
animals were trained to lever press for sucrose under a light cue specific rule, the 




rule was changed to a location specific rule and trials to criteria were measured. 
All animals were required to meet criteria for the visual rule in a minimum of 30 
trials before being tested in the location rule, and neither NAC treatment or stress 
exposure had an effect on initial learning (Figure 2-11A F(3,4) = 0.038, p = 0.989). 
Once the rule was switched, stress exposed animals took more trials to meet 
criteria when compared to sham exposed animals, signifying an impairment in 
cognitive flexibility, and NAC treatment surrounding the stressor prevented this 
learning deficit (Figure 2-11A, F(3,20) = 5.77, 0.005). Additionally, we found that 
stress exposed animals exhibited an increased number of perseverative errors 
when compared to all other treatment groups, and the increase in trials was not 
due to animals omitting lever presses (Figure 2-11B, F(3,20) = 4.46, p < 0.015). 
Additionally, NAC treatment in the absence of a stressor did not cause any 
changes in trials to criteria or perseverative errors. Taken together, these data 
indicate that NAC alone does not cause changes in operant learning and can 
prevent stress induced deficits in cognitive flexibility.  







 These experiments conclude that exposure to acute restraint stress causes 
escalations in ethanol seeking behavior during self-administration acquisition, 
extinction, and stress cue induced reinstatement. Additionally, stress exposure 
induces deficits in cognitive flexibility which could be contributing to the 
impairments observed in reinstatement testing. Further, NAC was successful at 
preventing both escalations in ethanol seeking as well as deficits in cognitive 
flexibly when administered either prior to stress, following the stressor, or at both 




time points. These data support the relationship between stress exposure and 
increased ethanol seeking and establish NAC as a pharmacological modulator that 
is affective at preventing stress induced relapse.  
 While there are a multitude of brain circuits involved in the establishment 
and maintenance of disorders like PTSD and AUD, the prefrontal cortex and its 
projections to the nucleus accumbens are especially important for relapse-like 
behaviors (Chen et al. 2010). These circuits are also altered following exposure to 
drugs of abuse, and this causes a variety of adaptations that can, in turn, reinforce 
the maladaptive behaviors that underly substance use (Lüscher and Malenka 
2011). In an addiction state, these projections have impaired plasticity which, in 
part, is induced by impairments in the regulation of glutamate homeostasis (Kalivas 
2009). Importantly, the connections between these regions have been shown to 
be involved in the ability to alter behavioral responses to a changing environment 
which is involved in the cognitive flexibility processes required for the extinction of 
drug-seeking and fear-related behaviors (Spencer et al. 2016). Additionally, 
prefrontal plasticity, glutamatergic function, and behavioral output have all been 
shown to be affected by exposure to an intensely stressful event (McEwen and 
Morrison 2013, Arnsten 2009). In animal models, dendritic morphology in the 
prefrontal cortex has been shown to be reduced following exposure to both 
pharmacological and behavioral models of extreme stress (Cook and Wellman 
2004), and this reduction in structural plasticity results in impaired functional 
plasticity as well (Jackson and Moghaddam 2006, Radley et al. 2015). These 




underlying changes in plasticity and glutamatergic functioning in the projections 
from the prefrontal cortex to the accumbens could play a role in the behavioral 
affects observed on drug seeking and reinstatement following exposure to restraint 
stress in these studies.  
NAC has been shown to modulate the brain through a number of different 
mechanisms. Primarily, the ability of NAC to affect the glutamatergic system has 
been the focus of its use for the treatment of addiction and anxiety disorders (Ooi 
et al 2018; McClure et al. 2014; Kupchik et al. 2012; Tomko et al. 2018; Zhou et 
al. 2008). NAC has been shown to affect glutamate homeostasis through multiple 
mechanisms including regulation of the cysteine-glutamate and glia glutamate 
transporters (Kupchik et al. 2013; Ooi et al 2018; Zhou and Kalivas 2009). Both of 
these glutamatergic modulators are impaired followed drug exposure and reduced 
expression of these transporters is associated with the reinstatement of drug-
seeking (Ooi et al. 2018). Specifically, NAC could be acting through these 
glutamatergic mechanisms to prevent stress cue induced relapse in these studies. 
Additionally, NAC has the ability to regulate antioxidant tone and multiple pro- and 
anti-inflammatory mediators (Minarini et al. 2017; Ooi et al. 2018; Šalamon et al. 
2019; Tardiolo et al. 2018; Mokhtari et al. 2017; Uraz et al. 2013; Sadowska et al. 
2007). Specifically, NAC has the ability to reduce levels of pro-inflammatory 
mediators such as TNF-a (Peristeris et al. 1992), IL-1b (Palacio et al. 2011), nitric 
oxide synthase (Bergamini et al. 2011), and activated microglia (Karalija et al. 
2012), and increases anti-inflammatory factors (Bavarsad-Shahripour et al. 2014). 




Since exposure to chronic ethanol (Fernandez-Lizarbe et al. 2009; Marshall et al. 
2016) and stress (Walker et al. 2013; Maydych 2019; Voorhees et al. 2013) has 
been shown to have the opposite affect by increasing pro-inflammatory factors, 
NAC acting as an antioxidant and anti-inflammatory agent could work to prevent 
the deleterious behavioral consequences that occur as a result of PTSD and AUD.  
While these experiments examined the behavioral effects of restraint stress 
exposure on ethanol seeking behavior and cognitive flexibility as well as the 
established the ability of NAC to treat these deficits, further studies need to be 
completed to determine the mechanism of action though which NAC is working to 
























INFRALIMBIC MGLU5 SIGNALING MEDIATES THE 
DELETERIOUS EFFECTS OF CHRONIC INTERMITTENT 




Background and Significance 
Post-traumatic stress disorder (PTSD) is one of the most highly observed 
conditions that occurs in patients that are in treatment for substance abuse and, 
as such, the rates of comorbidity between PTSD and alcohol use disorder (AUD) 
have been recorded to reach rates as high as 41–79% (Pietrzak et al. 2011). 
Additionally, there is greater clinical and functional impairment observed in those 
with both PTSD and AUD when compared to either disorder alone (Lehavot et al. 




2014), and there is evidence that PTSD symptoms are a significant risk factor for 
AUD which, in turn, interferes with PTSD treatment (Gaher et al. 2014). An 
additional area of interest with regards to comorbid PTSD/AUD focuses on 
differences between the sexes since these disorders often have different clinical 
profiles between men and women (Lebron-Milad and Milad 2012, Sonne et al. 
2003). Along with these clinical observations, preclinical examinations of sex 
differences in PTSD models have observed sexual dimorphisms in heritability, 
receptor expression, neuronal structure, and fear circuit functionality (Ramikie and 
Ressler, 2017). Therefore, for the purpose of these studies, an examination of sex 
differences was included to determine any differences in responses to fear stimuli 
following chronic ethanol.  
AUD and PTSD can often be classified as disorders of learning and memory 
(Hyman 2005; Vanelzakker et al. 2013) due to the complex interactions between 
alcohol and stress exposure in the prefrontal cortex. While alcohol can be abused 
by PTSD patients to help acutely alleviate their anxiety symptoms, in the long-term, 
alcohol abuse worsens PTSD symptoms and induces cognitive deficits that 
interfere with the extinction of trauma associated cues (Back et al. 2006). 
Additionally, these data reveal that anxiety disorders such as PTSD are affected 
by repeated alcohol use (Tipps et al. 2013), and chronic alcohol use also affects 
PTSD memories. Importantly, the first line behavioral therapies for both PTSD 
(Kessler et al. 1995) and drug addiction (Conklin and Tiffany 2002), including 
extinction-based exposure therapies, depend on these basic principles of learning 
and memory. Therefore, due to impairments in these processes associated with 




chronic alcohol exposure following stress, these therapies often have limited 
efficacy for these patients. Thus, targeting these learning and memory impairments 
with pharmacological modulators could serve to increase the effectiveness of 
these therapies in the treatment of comorbid PTSD and AUD. Following this line 
of research, previous studies in our lab have targeted the extinction phase of 
memory using cognitive enhancers that increase metabotropic glutamate receptor 
5 (mGlu5) activity to facilitate learning during this time (Cleva et al. 2011, Gass et 
al. 2014a, Gass and Olive 2009a). Additional studies have used mGlu5 modulators 
to enhance plasticity in the medial prefrontal cortex (mPFC) and demonstrate that 
mGlu5 mediated plasticity in the infralimbic subregion is necessary to block the 
expression of fear behaviors to allow for successful extinction (Fontanez-Nuin et 
al. 2011, Sepulveda-Orengo et al. 2013).  
Overall, the literature makes it clear that there is an interaction between 
alcohol exposure, fear extinction learning, and glutamate signaling in the IfL, but 
the exact nature of this relationship in comorbid PTSD/AUD is not clear. Therefore, 
the purpose of these experiments was to determine the effects of chronic 
intermittent ethanol vapor exposure on the extinction and recall of conditioned fear 
responses and to utilize manipulation of prefrontal glutamatergic systems to 
reverse these effects. An additional area of study within these experiments focuses 
on potential differences between males and females in responses to fear stimuli 
given the substantially different rates of prevalence of these disorders between the 
sexes.  
 




Materials and Methods 
Animals 
These experiments used male and female Wistar rats [postnatal day (PD) 
50 and 250-275 g upon arrival, Harlan, Indianapolis, IN] who were individually 
housed in standard polycarbonate cages. Throughout the experiment, access to 
food and water in the home cage was continuous except during behavioral testing. 
Animals were habituated to a 12:12 reverse light-dark cycle with lights off at 09:00 
am in order for experimental testing to be performed during the dark portion of the 
cycle. All experimental procedures were conducted with the approval of the 
Institutional Animal Care and Use Committee at the Medical University of South 
Carolina and within guidelines set forth by the National Research Council’s 
Guideline for the Care and Use of Mammals in Neuroscience and Behavioral 
Research (2003). A total of 96 animals across seven treatment groups for each 
sex were used in total for Experiments 1 and 2. Experiment 1 consisted of 
behavioral experiments completed using fear conditioning followed by CIE 
exposure and required three groups per sex that received the following treatments: 
Air+Vehicle, CIE+Vehicle, and CIE+CDPPB (n=8/sex, 48 animals total). 
Experiment 2 replicated these behavioral studies and also included treatment 
groups that received surgery to implant a microinjection canula for further 
manipulation, and required four groups that received the following treatments: 
CIE+Vehicle, CIE+CDPPB, CIE+CDPPB+MTEP in the IfL, and 




CIE+CDPPB+MTEP in the PrL (n=6/sex, 48 animals total). The overall 





3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide (CDPPB) was custom 
synthesized by Chemir Analytical Services (Maryland Heights, MO) according to 
previously published methods (Kinney et al. 2005, Lindsley et al. 2004), purified to 
>95% purity by liquid chromatography-mass spectrometry, and suspended in 10% 
v/v Tween-80 (Sigma-Aldrich). CDPPB was administered at a dose of 30 mg/kg 
and all injections were delivered subcutaneously. Previous studies in our lab have 
shown that 30 mg/kg CDPPB has the ability to facilitate extinction learning without 




resulting in any motor effects (Cleva et al. 2011, Gass et al. 2014, Gass and Olive 
2009a). MTEP [3-((2-Methyl-4-thiazolyl) ethynyl)pyridin hydrochloride] was 
purchased from Abcam Inc. (Cambridge, MA) and dissolved in sterile artificial 
cerebrospinal fluid (aCSF) to reach a final concentration of 5 μg/μl. This dosage is 
based on our previously published findings and was chosen to maximize blockade 
of mGlu5 receptor activity (Cannady et al. 2017, Gass et al. 2014, Sinclair et al. 
2012). Additionally, there have been no locomotor effects reported using similar 
doses of MTEP (Klodzinska et al. 2004, Martin-Fardon et al. 2009).  
 
Fear Conditioning Protocol 
Fear conditioning paradigms were completed following the protocol used in 
previously published works (Cain et al. 2002, Holmes et al. 2012, Izquierdo et al. 
2006, Sinclair et al. 2012, Wellman et al. 2007). Conditioning trials occurred once 
a day for a total of three days and lasted approximately five minutes per session 
to preclinically model characteristics of PTSD (Cain et al. 2012, Vanelzakker et al. 
2013). Each session consisted of a 120 second acclimation period, followed by 
four pairings of the tone (conditioned stimulus, CS, 30 sec, 80 dB, 3 kHz tone) with 
the footshock (unconditioned stimulus, US, 2 sec, 0.75 mA scrambled footshock) 
presented during the last 2 seconds of the tone. A 10 second inter-stimulus interval 
separated each tone/shock pairing. Conditioning criteria was met when rats 
displayed freezing behavior at least 80% of the time during the presentation of the 
CS. FreezeScan software (Clever Systems, Inc.) was used to determine freezing 




behavior from digitized videos (Milad and Quirk 2012, Sierra-Mercado et al. 2011, 
Quirk and Mueller 2008, Quirk et al. 2010). Treatment groups were behaviorally 
matched to ensure that all groups had similar levels of freezing prior to further 
manipulation. 
 
Chronic Intermittent Ethanol (CIE) Exposure 
CIE exposure was started following the completion of fear conditioning to 
model alcohol dependence that starts in response to the experience of a traumatic 
event and required repeated cycles of exposure to binge-like levels of ethanol 
through vapor inhalation. This is a highly characterized model of ethanol exposure 
that has been used by our lab (Gass et al. 2017, Trantham-Davidson et al. 2014) 
and others (Sanna et al. 2002, Ewin et al. 2019, Holmes et al. 2012, Singewald 
and Holmes 2019) to study the effects of chronic ethanol on the brain and behavior. 
For CIE exposure, animals were placed into an ethanol vapor chamber for 14 
hours a day for 14 consecutive days which left 10 hrs. of abstinence per day. As 
the rats were on a reverse 12-hour light/dark cycle with lights on at 9:00 pm and 
off at 9:00 am, CIE was planned to occur mostly during the lights on phase (6 pm 
to 8 am). To make sure that CIE did not have deleterious effects on the health of 
the animals, body weight and water intake were monitored throughout exposure. 
Animals in the control groups were transferred to the lab to remain in their home 
cages during the time period in which CIE animals were in the chambers. 
Intoxication levels were measured per rat at the end of each vapor exposure period 




using a 5-point motor intoxication rating scale (Nixon and Crews 2002) with a target 
of slight-to-moderate motor intoxication, or a rating of 2 to 3, respectively. BECs 
were determined from tail blood using a standard colorimetric assay at the end of 
exposure days 2, 6, 10, 15, using previously published methods (Gass and Glenn 
et al. 2014, Gass and Trantham-Davidson et al. 2014, Trantham-Davidson et al. 
2017). Fear extinction paradigms began 72 hours after CIE exposure ended to 
avoid any effects of alcohol withdrawal.  
 
Fear Extinction Testing 
An “ABBA” experimental design was used to determine the effects of CIE 
exposure on the extinction of fear responses to both the cue and context. The initial 
fear conditioning trials occurred in the original fear box with silver metal walls and 
silver grate flooring (context A) and cue extinction occurred in a novel, visually 
distinct context (B) that consisted of black paneled walls and solid plastic flooring. 
Each extinction session consisted of a 120 second acclimation period followed by 
10 presentations of the CS (tone), each lasting 30 seconds and separated by a 10 
second inter-stimulus interval. Extinction criteria was met when animals froze, on 
average, less than 30% of the time in response to the CS for 3 consecutive 
presentations of the CS. For those in the drug treatment groups, animals received 
CDPPB (30 mg/kg, subcutaneously) or vehicle (10% Tween-80, subcutaneously) 
20 minutes prior to each extinction session while all further testing was completed 
in a drug free state. 




Extinction Cue Recall and Context Recall 
Following the successful extinction of freezing behavior, animals were 
tested for extinction cue recall by placing them in the extinction environment 
(context B) and exposing them to a single tone presentation. These trials lasted 
for a total of 150 seconds, including a minute prior to and a minute following the 
30 second tone, and freezing behavior was measured in response to the tone. 
Subsequently, animals were tested for context-induced recall of freezing behavior 
by placing them in the original fear context A without presentation of the tone (Elias 
et al. 2010, Tovote et al. 2015). These tests were both included to determine the 
effects of CIE exposure on the retention of extinction learning for fear-associated 
cues and environments. 
 
Stereotaxic Microinjection Cannula Implantation 
For Experiment 2, a separate group of 48 rats performed the same 
behavioral paradigms, but with the addition of treatment groups that received 
microinjections of MTEP, an mGlu5 negative allosteric modulator, in the IfL or PrL 
to determine if CDPPB induced increases in mGlu5 activity in these regions is 
responsible for its facilitation of fear extinction learning. Surgeries to implant 
bilateral microinjection canula commenced between PD 50 and 56 and rats were 
allowed two weeks of recovery before beginning behavioral testing. Isoflurane was 
vaporized in medical grade breathing air at a flow rate of 0.4 L/min to anesthetize 




animals before placing them in a stereotaxic instrument (Kopf Instruments, 
Tujunga, CA). The microinjection cannula (26 ga O.D., Plastics One, Roanoke, 
VA) was implanted 1 mm dorsal to the IfL or PrL cortex, and the following 
stereotaxic coordinates were used: anterior/posterior + 3.24, medial/lateral ± 0.6, 
and dorsal/ventral − 3.8 for the IfL and anterior/posterior + 3.24, medial/lateral ± 
0.6, and dorsal/ventral −2.2 for the PrL (in mm from bregma and skull surface) 
(Paxinos and Watson 2005). Stainless steel screws were placed into the skull and 
were covered with dental cement to secure the microinjection cannula in place. To 
prevent tissue obstruction and contamination from debris, removable obturators 
(33 ga O.D.) were inserted in the full length of the guide cannula. Following 
surgery, the incision was sutured using 3-0 Vicryl sutures and treated with 2% 
xylocaine and 2% triple antibiotic ointments topically. Post-operative care 
consisted of daily injections of carprofen (2.5 mg/kg, s.c. for 5 days) for pain 
management. Once animals were allowed at least two weeks for surgical recovery, 




Microinjections of 5 μg/μl MTEP into either the PrL or IfL were completed 25 
minutes prior to each extinction session. Animals were lightly restrained to remove 
the obturators and insert sterile 33-gauge microinjection needles (Plastics One) 
connected through microbore tubing to two 100 μl syringes (Hamilton, Reno, NV). 




A micro-infusion pump held both syringes (Harvard Apparatus, Holliston, MA) and 
was set to deliver either MTEP or aCSF at a flow rate of 0.5 μl/min for a total of 
one minute. The microinjection needles were inserted to a depth 1 mm beyond the 
ventral tip of the guide cannula and were left in place for an additional minute 
following drug injection to allow for diffusion. Obturators were replaced following 
the removal of the microinjection needles, and animals in the CDPPB groups 
received subcutaneous injections (30 mg/kg) directly after each microinjection. 
Twenty minutes following the completion of both injections, animals were placed 
in the operant box for completion of the extinction training sessions as described 
above.  
 
Histological Verification of Microinjection Sites 
To obtain brain tissue for verification of cannula placement, rats were 
anesthetized with isoflurane and euthanized by decapitation following previously 
published methods (Gass et al. 2011). Following extraction, brains were placed 
into 10% v/v formalin for at least 1 week at 4°C, transferred to a 30% (w/v) sucrose 
solution for at least 72 hours at 4°C, and then immersed in 15% (w/v) sucrose for 
at least 72 hours at 4°C. A cryostat (Leica CM1900, Leica Microsystems, 
Bannockburn, IL) was used to section brains into 40-mm coronal slices and 
mounted onto microscope slides. These slides were stained with cresyl violet for 
histological verification of cannula placement using light microscopy. 




Determination of Estrous Cycle 
A small pilot study was conducted in a separate group of animals (n = 
6/group) to determine the impact of estrous cycle on fear extinction learning, since 
these processes have been shown to be altered based on cycle phase (Milad et 
al. 2009) To minimize any effects of the testing on behavioral outcomes, vaginal 
swabs were completed at the end of each extinction session (Gass et al. 2007, 
Ford et al. 2002, Roberts et al. 1998). This pilot experiment determined that there 
were no changes in fear extinction learning between females at different phases 
of the estrous cycle (Figure 3-2) and, thus, swabs were not completed on any 





Software including SPSS version 23.0 (SPSS Inc., Chicago, IL) and Prism 
version 8 (GraphPad software, La Jolla, CA) were used to analyze the behavioral 
data from these experiments. All tests required a p value of less than 0.05 for 




statistical significance. Fear conditioning data was analyzed using independent 
samples t-tests to compare the number of tone shock pairings needed to meet 
criteria between males and females. Extinction behavior data were analyzed using 
multiple two-way ANOVAs with Tukey’s multiple comparisons test performed 
between each treatment group on each day of extinction to compare behavioral 
responses to each individual conditioned stimulus presentation. An additional two-
way ANOVA was completed to analyze overall freezing throughout extinction to 
determine a main effect of treatment group on extinction learning. Animals were 
removed from analysis once individual freezing was indicative of successful 
extinction if it occurred prior to day five of extinction. Behavioral responses during 
recall testing were analyzed using a one-way ANOVA with multiple comparisons 
using Holm-Sidak post-hoc testing to determine differences in freezing between 
multiple treatment groups.  
 
Results 
Experiment 1 used a total of 48 male and female animals to determine how 
CIE exposure affects fear learning during extinction and how CDPPB treatment 
impacts CIE induced deficits in fear extinction. The experimental groups consisted 
of the following: Males and Females: Air+Vehicle vs. CIE+Vehicle vs. CIE+CDPPB 
(n=8/group, 6 groups total).  
 




Females meet fear conditioning criteria at a faster rate than males 
All animals must first meet criteria for fear conditioning in order for further 
analysis of fear extinction learning to be completed. All animals were freezing 80% 
of the time in response to the tone regardless of subsequent CIE or air treatment  
(Figure 3-4A), but females required significantly fewer tone/shock pairings to meet 
this criteria when compared to males [t(14) = 9.431, p < 0.0001, n=16/sex] (Figure 
3-4B). Although, while freezing rates differed between the sexes in the earlier 
phases of conditioning, all animals were freezing at a similar rate by the end of 
conditioning which allows for between group comparisons to be made during 








CIE exposure resulted in moderate levels of intoxication for all animals 
Following fear conditioning, animals were put into CIE exposure for a total 
of two weeks. Throughout CIE, a 5-point behavioral intoxication rating scale (Nixon 
and Crews 2002) was used to monitor the level of intoxication achieved following 
each 14-hour ethanol exposure period. The goal for these experiments was a 
behavioral intoxication rating of 2-3 which correspond to moderate levels of 
intoxication. Throughout both Experiment 1 and Experiment 2, there were a total 
of 80 male and female animals in CIE treatment groups and intoxication ratings 
were averaged for all animals across exposure sessions. An overall average 
intoxication rating of 2.2 ± 0.05 was achieved across all exposure periods and 
animals. Blood ethanol concentrations were determined from tail vein puncture 
directly following CIE exposure on days 2, 6, 10, and 15 to serve as a 
complementary measure to the behavioral intoxication ratings. To achieve 
moderate intoxication ratings, BEC target values were between 200 – 300 mg%. 
Average BEC mg% values for males were recorded to be 249.6 ± 24.5 (Day 2), 
240.3 ± 20.6 (Day 6), 230.2 ± 19.8 (Day 10), and 221.3 ± 29.54 (Day 15) with an 
overall grand average across all 4 days of 235.4 ± 23.6. Females exhibited 
average BEC mg% values of 259.2 ± 16.39 (Day 2), 279 ± 26.4 (Day 6), 251.9 ± 
12.4 (Day 10), and 235.4 ± 18.57 (Day 15) with an overall grand average across 
all 4 days of 256.4 ± 18.4 (Figure 3-3) 






Deficits in fear extinction learning are established following CIE exposure and are 
treated with CDPPB 
Following CIE exposure, animals were subjected to extinction training for a 
total of five days. When examining the average freezing response on day of 
extinction (Figure 3-5) there was a main effect of CIE on extinction learning such 
that CIE exposed animals showed increased levels of freezing when compared to 
air treated animals across the total duration of extinction training. Specifically, 
males exposed to CIE exhibited significantly higher average rates of freezing to 
the CS across multiple days of extinction training when compared to air-exposed 
controls (Figure 3-5A) [F (49, 489) = 24.25, p < 0.0001, n=8/group]. The same 
effect was observed in females as well, where animals exposed to CIE also 
exhibited significantly higher rates of cue-induced freezing when compared to air 




exposed controls throughout extinction [F (49, 500) = 34.58, p < 0.0001, 
n=8/group] (Figure 3-5B). Notably, treatment with CDPPB was effective at 
attenuating CIE induced deficits in extinction through the facilitation of extinction 
learning. There was a significant effect of CDPPB on extinction learning such that 
CDPPB treatment reduced freezing during extinction in CIE exposed animals 
across the entirety of extinction for both males [F(49, 481) = 30.58, p < 0.0001, 
n=8/group] (Figure 3-5A) and females [F(49, 500) = 31.19, p < 0.0001, n=8/group) 










CIE differentially affects extinction cue and context recall between the sexes 
Two days following the completion of extinction training, animals were 
tested for extinction cue recall through the presentation of a single tone in Context 
B. A clear sex difference emerged during this test, since there was a significant 
effect of CIE on cue recall in male, but not female, animals. Those exposed to CIE 
prior to extinction exhibited an increased rate of freezing when compared to both 
air exposed controls and CIE exposed male animals treated with CDPPB [F(2,21) 
= 35.74, p < 0.0001, n = 8/group] (Figure 3-6A). This effect was not observed in 
female animals, where those exposed to CIE did not differ in freezing behavior 
from either air exposed controls or CDPPB treated animals [F(2,21) = 0.7977, p = 
0.4636, n = 8/group] (Figure 3-6B).  
 




Following the extinction recall test, animals were placed back into the 
original conditioning environment (context A) in the absence of any tone 
presentation to assess freezing in response to the context only. Notably, all drug 
manipulation occurred previously during extinction training, and all recall testing 
was performed in a drug-free state. During this test, CIE-exposed male rats 
showed a significant increase in context-induced freezing compared to both air-
exposed controls and CIE-exposed animals that were treated with CDPPB prior to 
each extinction session [F(2,21) = 9.66, p = 0.001, n = 8/group] (Figure 3-7A). 
Additionally, this treatment effect was observed in females as well, where there 
was a significant increase in freezing to the context see in CIE treated animals 
compared to air exposed controls and CIE+CDPPB animals [F(2,21) = 22.85, p < 
0.0001, n = 8/group] (Figure 3-7B).  
 




CDPPB facilitates extinction learning through increases in mGlu5 activity in the 
infralimbic cortex 
The behavioral studies in Experiment 1 determined that CDPPB can 
recover CIE induced deficits in fear extinction learning in both male and female 
animals. Previous studies carried out in our lab using CDPPB found that the 
enhancement of extinction of drug-seeking behaviors was associated with the 
formation of calcium permeable AMPA receptors specifically in the IfL region of the 
PFC (Gass et al. 2014). Therefore, in Experiment 2, we examined whether 
CDPPB’s effects were dependent upon activation of mGlu5 receptors selectively 
in the IfL cortex using the following treatment groups: Males and Females: 
CIE+Vehicle vs. CIE+CDPPB vs. CIE+CDPPB+MTEP in the IfL vs. 
CIE+CDPPB+MTEP in the PrL (n=6/group, 8 groups total). 
During extinction, there was a significant main effect of treatment in male 
rats where those administered CIE+CDPPB+MTEP exhibited freezing levels 
similar to CIE animals that did not receive any treatment [F(49, 495) = 24.54, p < 
0.0001, n=6/group] (Figure 3-8A). Essentially, microinjections of MTEP into the IfL 
cortex concurrent with CDPPB treatment blocked its facilitating effects on 
extinction learning. Additionally, a similar effect was observed in female animals 
where local administration of MTEP into the IfL cortex just prior to systemic CDDPB 
administration prevented the facilitating effects of CDPPB on fear extinction 
learning, since CIE+CDPPB+MTEP treated animals exhibited increased levels of 




freezing when compared to CIE+CDPPB treated animals across multiple extinction 




MTEP delivered into the IfL blocks the ability of CDPPB to prevent increases in 
freezing during recall testing 
During cue recall testing in context A, CIE+CDPPB animals that received 
MTEP microinjected into the IfL exhibited increases in freezing behavior when 
compared to CIE+CDPPB treated animals. MTEP treated animals also displayed 
freezing similar to those exposed to CIE that did not receive CDPPB treatment 
[F(2,15) = 27.62, p < 0.0001, n = 6/group] (Figure 3-9A). This data suggests that 
when mGlu5 activity is blocked in the IfL so is CDPPB’s ability to prevent CIE 




induced increases in freezing during recall. Additionally, due to a lack of effect of 
CIE on cue recall in female animals, and there were no differences observed 
between female treatment groups [F(2,15) = 0.5237, p = 0.6028, n = 6/group] 




MTEP microinjections resulted in a similar effect on context recall in both 
sexes. There was a significant effect of treatment on freezing during context recall, 
since CDPPB treatment resulted in decreased freezing when compared to CIE 
exposed animals, and MTEP treatment in these animals prevented the reduction 




in freezing to the context shown following CDPPB treatment in males [F(2,15) = 
12.04, p = 0.0008, n =6/group] (Figure 3-10A) and females [F(2,15) = 17.16, p = 
0.0001, n = 6/group] (Figure 3-10B). Essentially, CIE+CDPPB+MTEP treated 
animals exhibited freezing similar to CIE+Vehicle animals, signifying a lack of 
treatment effect of CDPPB when mGlu5 is blocked in the IfL. Additionally, 
histological examination of the injection site demonstrated that all microinjections 
were within the IfL cortex or its boundary regions (Figure 3-11).  
 
 






Reduction of mGlu5 activity in the prelimbic cortex does not affect CDPPB’s ability 
to reverse CIE induced deficits in extinction learning  
Animals were exposed to the same fear conditioning and CIE model 
followed by CDPPB treatment and MTEP administration during fear extinction, but 
microinjections occurred in the PrL cortex. Following blockade of mGlu5 activity in 
the PrL using MTEP, CDPPB treatment was still effective at attenuating CIE-
induced deficits in extinction learning for both males [F(49,494) = 18.4, p < 0.0001, 
n=6/group] (Figure 3-12A) and females F(49, 493) = 29.78, p < 0.0001, n=6/group] 
(Figure 3-12B). Essentially, the ability of CDPPB to facilitate extinction learning 
was not dependent on increases in mGlu5 in the PrL cortex. 
 






MTEP negative allosteric modulation of mGlu5 activity in the PrL did not affect CIE 
induced increases in freezing during recall 
In cue recall testing, CIE exposed animals exhibited a significantly 
increased level of freezing when compared to CIE+CDPPB treated animals, and 
MTEP treatment did not stop CDPPB from decreasing freezing during this session. 
There was still a significant effect of treatment where CDPPB was still able to act 
as an effective treatment on CIE induced heightened freezing during cue recall 
[F(2,15) = 21.96, p < 0.0001, n = 6/group]  (Figure 3-13A). Due to the lack of 
change in freezing behavior as a result of CIE exposure in female animals, and 
there were no differences in freezing between any of the treatment groups during 
cue recall testing [F(2,15) = 1.196, p = 0.3296, n = 6/group] (Figure 3-13B).  
 






CIE treated animals also exhibited significantly higher rates of freezing to 
the context when compared to those that received CIE+CDPPB and 
CIE+CDPPB+MTEP treatment in males [F(2,15) = 12.7, p = 0.0006, n = 6/group] 
(Figure 3-14A) and females [F(2,15) = 8.358, p = 0.0036, n = 6/group] (Figure 3-
14B). This indicates that when mGlu5 is blocked in the PrL, CDPPB is still able to 
work as a treatment to prevent heightened freezing in response to the context for 
both sexes. Histological examination revealed that all microinjections were found 
to be contained within the PrL cortex or its boundary regions (Figure 3-15). 
Together, these findings indicate that mGlu5 activity in the IfL cortex, but not the 




PrL cortex, is required for CDPPB to attenuate deficits in fear extinction and recall 
that result from chronic ethanol exposure.  
 
 





These experiments indicate that stress exposure followed by chronic 
ethanol intake leads to impairments in fear extinction and memory recall. 
Additionally, these studies illustrate that the enhancement of mGlu5 activity in the 
infralimbic cortex has the ability to reverse these CIE induced deficits in both 
sexes. In CIE exposed animals, treatment with the mGlu5 positive allosteric 
modulator, CDPPB, prior to each extinction training session was able to facilitate 
extinction learning and prevent heightened freezing during cue and context recall. 
We were able to determine that the IfL cortex is necessary for CDPPB’s effects on 
extinction learning by microinjecting the mGlu5 negative allosteric modulator 
MTEP in either the prelimbic or infralimbic cortex in combination with systemic 
CDPPB administration, Further, sex differences were found with regards to initial 
responses to fear stimuli during conditioning, as well as to extinction cue recall 
testing. The current set of studies provide newly discovered beneficial effects of 
CDPPB treatment on fear extinction and attenuation of heightened cue- and 
context-induced freezing following chronic alcohol exposure. 
When examining preclinical data there are always a number of limitations 
that need to be addressed due to the complexity of modeling neuropsychiatric 
disorders across species. First, examinations of estrous cycle were limited to a 
small pilot study and were not completed for all animals included in these 
experiments. Additionally, this pilot compared the behavior of animals starting in 
metestrus/diestrus vs. proestrus/estrus instead of separating out all four phases 




into different groups. Regardless, due to the fact that the within group variability is 
low and the rate of extinction is very similar between the groups, this provides initial 
support that cycle phase is not altering extinction behavior. Further published 
studies support these conclusions and determined that the rate of fear extinction 
does not differ between females in proestrus vs. metestrus, and that females 
administered estrogen prior to extinction displayed freezing behavior similar to 
those that received vehicle (Maeng et al. 2015). While these studies did include a 
wide variety of treatment groups, there were no animal cohorts that received only 
CDPPB or MTEP in the absence of prior ethanol exposure. Previous work has 
shown that CDPPB has the ability to enhance the extinction of ethanol seeking 
behaviors during self-administration paradigms, so we would assume that the 
cognitive enhancing effects would still be present when CDPPB treatment is 
delivered without prior CIE exposure. Although published studies often focus on 
the ability of CDPPB to enhance the extinction of drug seeking behaviors, it has 
been reported that CDPPB can enhance fear extinction learning and recall (Sethna 
and Wang 2014). While not included within this study, MTEP has been delivered 
as a systemic treatment and has been found to have off target effects on behavior 
(Simonyi et al. 2010; Pietraszek et al. 2005; Schulz et al. 2001). Alternatively, these 
studies microinjected MTEP into select brain regions and, as such, negative 
allosteric modulation of mGlu5 was restricted to these regions and the behavioral 
effects that are observed when MTEP is administered systemically are not 
expected to occur in these studies. An additional limitation in these studies comes 
from the fact that a single dose of CDPPB and MTEP was used and a dose-




response curve was not examined. Due to the lab’s experience using these drugs, 
multiple doses of CDPPB and MTEP have been tested to optimize CDPPB’s 
effects on extinction learning and this dose-response curve has been previously 
established (Gass and Olive 2009a; Gass and Olive 2009b; Gass et al. 2014; Gass 
et al. 2017; Widholm et al. 2001; Cleva et al. 2011). When testing 0.3, 3, or 30 
mg/kg CDPPB, 30 mg/kg CDPPB was necessary to induce significant effects on 
extinction learning that were prevented with MTEP delivered intraperitoneally. 
There were no effects on locomotor behavior or any changes in neurotoxicity when 
CDPPB was administered at this dose (Gass and Olive 2009a). Additionally, 
previous studies were completed that examined MTEP dosing and found that, 
while 1 ug/uL was not sufficient to alter behavior and 10 ug/uL led to a reduction 
in locomotor activity, the 3 ug/uL concentration was able to reduce ethanol seeking 
without altering locomotor activity (Gass and Olive, 2009b). Therefore, the doses 
of both CDPPB and MTEP used in these studies have been thoroughly validated 
to have optimal effects on learning without causing deleterious side effects.  
Taken together, the results from these experiments demonstrate multiple 
behavioral deficits that occur as a result of stress and alcohol dependent 
alterations in learning and memory due to impairments in infralimbic mGlu5 
activity. These studies identify CDPPB as a pharmacological treatment that has 
the potential to rescue alcohol induced deficits in learning and memory that could 
be efficacious in treating these deficits often observed in the clinical PTSD/AUD 
population. Additionally, the current findings identify potential brain mechanisms 




that underlie the detrimental effects of comorbid alcohol and stress exposure and 


























OPTOGENETIC MANIPULATION OF THE PRELIMBIC 
CORTEX DURING FEAR MEMORY RECONSOLIDATION 
ALTERS FEAR EXTINCTION IN A PRECLINICAL MODEL 




Background and Significance 
 
Post-traumatic stress disorder (PTSD) and alcohol use disorder (AUD) are 
two highly debilitating psychology conditions that do not have many effective 
treatment options. While there is a lifetime prevalence of 8.3% and 29.1% for 
PTSD and AUD respectively, the presence of PTSD leads to a three times greater 
chance of also developing AUD (Gilpin and Weiner 2017). As such, the rate of 




comorbidity between PTSD and AUD has been recorded to be as high as 30% - 
59% (Jacobsen et al. 2001). This is especially true for the military population, 
where combat exposure was significantly associated with binge drinking behavior 
and alcohol-related problems (Jacobson 2008), and alcohol has been established 
as the most abused drug among veterans with PTSD (Gilpin and Weiner 2017). 
Not only is there a higher lifetime prevalence of AUD in PTSD patients, but the 
comorbid presence of these disorders causes more severe symptomology and 
worse treatment outcomes (Neupane et al. 2017). For specific PTSD symptom 
subtypes, including trauma reexperiencing and psychiatric distress, those using 
alcohol reported a higher degree of symptom severity with poorer PTSD/AUD 
treatment outcomes (Read et al. 2004). Interestingly, PTSD has a higher incidence 
rate in female patients than male patients and there are sex-specific differences in 
PTSD incidence, severity of symptoms, and propensity to use alcohol as a coping 
strategy (Lehavot et al. 2014, Sonne et al. 2003). Since the prevalence of comorbid 
PTSD and AUD is increasing and leads to worse symptomology and treatment 
outcomes, there is increasing need for research into the underlying neurobiological 
processes that are related to the establishment and maintenance of these 
disorders. Further, these established sex-differences in the clinical population 
make it increasingly important to conduct preclinical studies in both male and 
female animals to determine optimal treatment strategies between the sexes. 
The establishment and treatment of both PTSD and AUD rely on learning 
and memory systems that overlap in the prefrontal cortex (PFC). There have been 
both functional and structural alterations observed in the infralimbic (IfL) and 




prelimbic (PrL) regions of the medial PFC (mPFC) in patients with PTSD and AUD 
(Gilpin and Weiner 2017). Additionally, these regions have important functions in 
the promotion and suppression of fear and drug seeking behaviors (Peters et al. 
2009). Importantly, the most common psychological treatment strategies for PTSD 
and AUD rely on intact mPFC processes, and impaired functionality of these areas 
might explain why these treatments do not have a high rate of efficacy (Conklin et 
al. 2002). Specifically, one common method of AUD and PTSD treatment involves 
exposure therapy, where exposure to trauma or drug related cues occurs in a safe 
and controlled environment to allow the patient to form new associations between 
these cues and their conditioned responses (Watkins et al. 2018). This treatment 
method involves many facets of learning and memory systems that rely on the PFC 
including memory reconsolidation and extinction (Cooper et al. 2017). Memory 
reconsolidation is a process that allows memories that have already been 
consolidated into long-term storage to be retrieved and updated with new 
information (Nader et al. 2015). This is also important for extinction learning during 
which new associations are formed between previously established cues and 
responses (Quirk et al. 2008). While these learning and memory processes are 
required for PTSD and AUD treatments to be effective, clinical and preclinical data 
have found them to be impaired following exposure to alcohol (Bisby et al. 2015, 
Kroener et al. 2012, Smiley et al. 2020). As such, a novel line of research has 
emerged that focuses on targeting these learning and memory processes with 
pharmaceutical treatments to enhance the effectiveness of the extinction learning 




reliant therapies used to treat PTSD and AUD (McGuire et al. 2014; Gass et al. 
2014b).  
Our lab has recently established that both male and female animals 
exposed to chronic binge-like levels of ethanol exhibit deficits in the ability to 
extinguish fear cue associations during extinction learning. We also determined 
that this process was dependent on glutamatergic activity at metabotropic 
glutamate receptor 5 (mGlu5) receptors specifically in the IfL region of the mPFC 
(Smiley et al. 2020). The current set of experiments was designed to further 
examine the relationship between alcohol exposure and fear related learning and 
memory and the involvement of the PrL and IfL subregions. Rats were first 
exposed to fear conditioning followed by chronic intermittent ethanol exposure 
(CIE) to model the clinical pattern of trauma exposure followed by binge ethanol 
intake. Optogenetics was then used to manipulate the prelimbic and infralimbic 
regions of the mPFC during fear memory reconsolidation to test the hypothesis 
that blockade of PrL fear promotion during fear memory reconsolidation would lead 
to a decrease in the presentation of fear behaviors during extinction. These data 
provide important information regarding the role of the mPFC in fear learning and 
memory that is impaired following exposure to chronic ethanol and support the 









Materials and Methods 
 
Animals  
Wistar rats (48 male, 48 female, postnatal day 55 on delivery, Charles River 
Laboratories) were pair housed in standard polycarbonate cages with food and 
water continuously available except for during behavioral testing. Prior to 
experimental manipulation, animals were habituated to a 12:12 reverse light-dark 
cycle. All behavioral testing was then performed during the dark phase of the cycle. 
Approval by the Institutional Animal Care and Use Committee at the Medical 
University of South Carolina was achieved for all experimental testing under the 
guidelines of the National Research Council’s Guideline for the Care and Use of 
Mammals in Neuroscience and Behavioral Research (2003). A total of 96 animals 
were used for these studies and were assigned to the following treatment groups 
outlined in Table 4-1.  
 
 







Experiments followed the overall design and timeline presented in Figure 
4-1. For all surgical procedures, rats were anesthetized with isoflurane and oxygen 
at a flow rate of 0.4 L/min and placed in a stereotaxic device (Kopf Instruments). 
For Experiment 1, animals received a unilateral injection either 0.5 uL of pAAV-
CaMKIIa-eNpHR3.0-eYFP or an EYFP reporter construct (UNC Viral Vector Core, 
Chapel Hill, NC) injected at a rate of 0.1 uL per minute in to the prelimbic cortex 
(PrL). The stereotaxic coordinates used for the PrL were as follows: 
anterior/posterior + 3.24, medial/lateral ± 0.6, and dorsal/ventral -2.2 (in millimeters 
from bregma and the skull surface). Experiment 2 followed the same procedure, 
but virus was instead injected in the IfL at the following coordinates: 
anterior/posterior +3.24, medial/lateral ± 0.6, and dorsal ventral -3.8 (in millimeters 
from bregma and the skull surface). For all surgeries, the injection needle 
(Hamilton, 1 uL syringe) was mounted in a micro-infusion pump (Harvard 




Apparatus) and kept in place for 10 minutes following the injection to allow for virus 
diffusion. The fiber optic implant (Thorlabs Inc., Newton, NJ) was then placed 
directly dorsal to the virus injection site and stainless-steel screws covered in 
dental cement were used to secure the implant to the skull. The wound was sutured 
with 3-0 Nylon sutures and treated with 2% triple antibiotic ointment. Rats were 
post-operatively treated with antibiotics (cefazolin, 0.3 mL, s.c.) and carprofen 
analgesic (0.4 mL, s.c.) for three days following the surgery. Following the 
completion of all behavioral procedures, rats were perfused with 0.9% saline 
followed by 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer. Following 
extraction, brains were kept in 4% PFA for 48 hours before being transferred to 
20% sucrose for an additional 72 hours. Brains were frozen and coronal slices 
were sectioned at 40 um and examined for fluorescence to histologically verify 
virus and fiber placement. 
 
Fear Conditioning Paradigm  
All behavioral testing was performed in standard operant boxes (Med 
Associates Inc., Fairfax, VT) contained within sound attenuating chambers. 
Auditory fear conditioning procedures began nine days after surgery to allow for 
recovery. Animals were operantly conditioned using four pairings of a tone 
(conditioned stimulus [CS] - 30 sec, 80 dB, 3 kHz) with a 0.75 mA foot-shock that 
occurred during the last two seconds of the tone. A 60 second habituation period 
occurred at the start of each session, and each tone/shock pairing was separated 
by a ten second inter-stimulus interval. This conditioning protocol was repeated for 




a total of three days until all animals achieved conditioning criteria of freezing for 
80% of tone. Freezing during each session was digitally determined by 
FreezeScan (CleverSys Inc., Reston, VA) (Milad and Quirk 2012, Sierra-Mercado 
et al. 2011, Quirk and Mueller 2008, Quirk et al. 2010). This protocol has been 
used by our lab (Smiley et al. 2020, Gass et al. 2014a, b, Gass et al. 2017, Gass 
and Olive 2009) and others (Singewald et al. 2014, Singewald and Holmes 2019, 
VanElzakker et al. 2013) as a preclinical model of stress exposure used to evaluate 
fear learning and memory (Cain et al. 2012, VanElzakker et al. 2013). 
 
Chronic Intermittent Ethanol Procedure 
Once fear conditioning criteria was met, animals were exposed to a two-
week chronic intermittent ethanol (CIE) protocol. CIE chambers consisted of clear 
acrylic boxes that measured 24 × 24 × 14 inches (Plas Labs; Lansing, MI), and 
pair-housed cage mates were placed in the same chamber for a total of 15 nights 
from 1800 hours in the evening until 0800 hours the next morning. This schedule 
resulted in a total of 14 hours of vapor exposure and 10 hours of abstinence each 
day. A five-point behavioral scale was used to monitor individual levels of 
intoxication for each animal. Briefly, motor impairment was assigned a rating based 
on the following behaviors: 1 - no signs of intoxication, 2 - slightly intoxicated (slight 
motor impairment), 3 - moderately intoxicated (obvious motor impairment but able 
to walk), 4 -highly intoxicated (dragging abdomen, loss of righting reflex), 5 - 
extremely intoxicated (loss of righting reflex and loss of eye blink reflex) (Nixon and 
Crews, 2002). The goal of each exposure session was to achieve moderate 




intoxication with a behavioral rating of 2-3, and this level of intoxication has been 
consistently shown in our lab to correspond to ~200-300 mg/dl blood ethanol 
concentration (BEC) (Smiley et al. 2020, Trantham-Davidson et al. 2014, Gass et 
al. 2014a, Gass et al. 2017, Uys et al. 2016). Body weight was monitored 
throughout this procedure to maintain the health of the animals. Additionally, 
control animals were treated similarly by bringing them into the lab and placing 
them outside of the chambers throughout exposure.  
 
Memory Reactivation and Optogenetic Stimulation Parameters 
Two days following the end of CIE, animals were exposed to fear memory 
recall paired with optogenetic inhibition of the PrL or IfL to block fear memory 
reconsolidation. Fear memories were reactivated through the presentation of the 
conditioned fear cues including the fear environment as well as the tone that 
previously served as the conditioned stimulus. Animals received optogenetic 
inhibition during the memory reconsolidation period in their home cage 
immediately following the presentation of the fear associated cues. Photoactivation 
was induced by 532 nm light delivered intracranially for three minutes (10 Hz 
pulses, 15 ms pulse duration, 10 mW illumination). 
 
Fear Extinction and Spontaneous Recovery 
Following this initial fear memory reactivation, animals completed a total of 
five extinction sessions to monitor freezing behavior in response to the CS to 
determine the effect of optogenetic inhibition of the PrL or IfL cortex during memory 




reconsolidation on extinction learning. All extinction sessions consisted of ten 
presentations of the tone (CS) for thirty seconds separated by a 10 second inter-
stimulus interval. There was no shock delivered during these sessions, and 
freezing was recorded during each tone presentation. Extinction criteria was met 
when animals were freezing less than 30% of the time in response to the CS. Once 
animals successfully met this criterion, there was a three-week break before they 
were placed back into the operant boxes for a single session during which the CS 
was presented a single time and freezing was measured for the duration of the 
tone (30 seconds) to measure the spontaneous recovery of fear behaviors. 
Importantly, optogenetic inhibition was only administered following the initial fear 
memory reactivation, and all extinction and recall testing was completed without 
any photostimulation. 
 
Statistical Analyses  
The primary dependent variable measured for the fear conditioning, 
extinction, and spontaneous recovery sessions was percent freezing in response 
to the conditioned stimulus (tone). These behavioral data were analyzed using 
SPSS version 23.0 software (SPSS Inc., Chicago, IL) and Prism version 8 
(GraphPad software, La Jolla, CA). Both fear conditioning and extinction data were 
analyzed using a 2-way ANOVA with Holm-Sidak multiple comparisons as the 
post-hoc test used to determine differences between each treatment group. 
Extinction data were analyzed as an average response to all ten CS presentations 
for each day of extinction. For spontaneous recovery data, an ordinary one-way 




ANOVA with Holm-Sidak multiple comparisons test used to compare all four 
treatment groups. All experiments used an n of 6 animals/treatment group, and a 




These experiments used chronic intermittent ethanol exposure to model 
alcohol dependence with binge-like levels of ethanol exposure. This highly 
characterized model has been previously used by our lab to establish deficits in 
fear- and drug-related learning (Smiley et al. 2020; Gass et al. 2017). A five-point 
behavioral intoxication scale (Nixon and Crews 2002) was used to gauge 
intoxication levels in each of the animals with a target of moderate intoxication 
corresponding to a 2-3 rating. A subset of 72 (36M, 36F) out of the total 96 animals 
underwent CIE exposure, and the intoxication ratings were averaged between 
each sex and across all exposure periods. The intoxication score average across 
all days and all rats was 2.8 ± 0.09. As a complementary measure to the behavioral 
intoxication rating, blood ethanol content (BECs) was obtained from tail vein 
puncture following exposure periods on days 2, 6, 10, and 15. The target range for 
BEC was between 200 – 300 mg%, and our analysis revealed average BEC mg% 
values for males of 267.36 ± 29.17 (Day 2), 262.4 ± 27.21 (Day 6), 251.8 ± 26.3 
(Day 10), and 239.54 ± 24.6 (Day 15) with an overall grand average across all 4 
days of 255.3 ± 26.82. For the females, our analysis revealed average BEC mg% 
values of 261.7 ± 25.45 (Day 2), 265.5 ± 28.76 (Day 6), 257.11 ± 22.52 (Day 10), 




and 242.08 ± 19.73 (Day 15) with an overall grand average across all 4 days of 




Prelimbic inhibition during fear cue memory reconsolidation facilitates extinction 
learning  
In Experiment 1, we examined the effect of PrL inhibition during fear 
memory reconsolidation on fear extinction learning in a rat model of PTSD/AUD. 
Experimental procedures were completed following the outline in Figure 4-1. The 
treatment groups used for Experiment 1 included comparisons between animals 
that received CIE without PrL Inhibition (CIE-NI), CIE with PrL Inhibition (CIE-I), 
CIE without a surgical implant (CIE), and air (Air) for each sex.  
Prior to extinction testing, all animals were required to meet a criteria of 
freezing 80% of the time in response to the tone (conditioned stimulus, CS) during 
the fear conditioning phase. Analysis of freezing behavior during this phase of 




training was completed to ensure that all animals received the same degree of fear 
conditioning before subsequent experimental manipulation. In Figure 4-3, each 
data point represents an average of the freezing responses to the four CS 
presentations that occur on each day of conditioning. For male animals, there was 
a significant difference in freezing to the CS between treatment groups during the 
initial CS presentations (Figure 4-3A, F(3, 20) = 14.94, p < 0.0001), but there were 
no significant differences between the groups by Day 3 (F(3, 20) = 0.8281, p = 
0.4939), and all animals met the 80% criteria. For females, there was no significant 
difference in freezing behavior throughout conditioning between any treatment 
groups (Figure 4-3B, F(3, 60) = 1.998, p = 0.1239), and all animals were freezing 








Animals were permitted a two-day break to allow for fear memory 
consolidation after conditioning, and were subsequently exposed to two weeks of 
CIE. The following week, animals were put back into the fear context and exposed 
to a single presentation of the CS (tone) to induce fear memory recall. Freezing 
was measured during this fear recall session and analysis revealed no differences 
between any groups in baseline freezing during this session (Figure 4-4). 
Immediately following the fear memory recall session, optogenetic inhibition of the 
PrL occurred during the memory reconsolidation phase and freezing to the CS was 
measured across five subsequent extinction sessions. Each bar depicted on 
Figure 4-4 is representative of average freezing to a total of 10 tone presentations 
on each extinction day. For male animals there was a main effect of treatment on 
freezing to the CS throughout extinction (Figure 4-4A, F (3, 120) = 25.83, p < 
0.0001). As shown in Figure 4-4A, CIE exposed animals that did not receive 
surgical implants exhibited significantly higher levels of freezing when compared 
to air exposed animals throughout extinction which replicates our recently 
published studies regarding CIE’s effects on extinction learning (Smiley et al. 
2020). Additionally, these experiments found that inhibition of the PrL during fear 
memory reconsolidation prevented CIE induced deficits in extinction learning, 
since CIE-I animals exhibited significantly lower levels of freezing when compared 
to the CIE-NI and CIE groups. This was also observed in female animals where 
there was a main effect of treatment on freezing in response to the tone throughout 
extinction training (Figure 4-4B, F (3,120) = 21, p < 0.0001). In these animals, CIE 
exposure led to deficits in extinction learning with CIE exposed animals exhibiting 




higher levels of freezing to the CS compared to air exposed animals throughout 
extinction. Furthermore, these experiments found that blockade of PrL activity 
during fear memory reconsolidation had the ability to enhance extinction since CIE-
I animals exhibited significantly lower rates of freezing when compared to CIE-NI 
and CIE animals on multiple days of extinction training. Individual differences 
between all treatment groups on each extinction day are shown in Figure 4-4 




Following extinction, animals were permitted a three-week break before 
being tested for spontaneous recovery of fear behavior in response to the fear 
context and a single CS (tone) presentation. Blockade of fear memory 
reconsolidation, through inhibition of the PrL cortex during the initial fear memory 




recall session, prevented the spontaneous recovery of freezing behavior in male 
and female animals, which supports the hypothesis that PrL inhibition disrupted 
fear memory reconsolidation. There was a main effect of treatment for males (F 
(3, 20) = 8.594, p = 0.0007) where CIE exposed animals exhibited heightened 
freezing when compared to air exposed controls, and CIE-I animals froze 
significantly less than the CIE-NI group (Figure 4-5A). This was also observed in 
females, where CIE and CIE-NI exposed animals exhibited a significantly higher 
rate of freezing when compared to air exposed controls and the CIE-I group 
(Figure 4-5B, F (3, 20) = 8.493, p = 0.0008). Essentially, manipulation of fear 
memory reconsolidation through inhibition of the PrL had long term effects on fear 
behaviors elicited in response to previously conditioned fear cues. Individual 
differences between the groups are noted on Figure 4-5 where * = CIE-NI vs. CIE-
I and + = CIE vs. Air. 
 






Infralimbic inhibition following fear cue exposure does not alter extinction learning 
For Experiment 2 we used the same methodology described above, but 
optogenetic inhibition was instead targeted to the IfL cortex. The treatment groups 
used for Experiment 2 included animals that received CIE without IfL Inhibition 
(CIE-NI), CIE and IfL Inhibition (CIE-I), CIE without a surgical implant (CIE), and 
air (Air) for each sex. Prior to any experimental manipulation, freezing behavior 
during fear conditioning was examined to confirm that the responses to fear stimuli 
were consistent between treatment groups. For male animals, on Day 1 of 




conditioning, there were significant differences between animals who would 
subsequently receive different treatments (F (3, 20) = 6.085, p = 0.0041), but by 
Day 3 of conditioning all animals met freezing criteria of 80% and there were no 
differences between any treatment groups (Figure 4-6A, F (3, 20) = 1.414, p = 
0.2680). This trend was similar in female groups, where on Day 1 there were 
significant differences between the groups (F (3, 20) = 4.870, p = 0.0106), but by 
Day 3 there were no differences between any groups and all animals were freezing 











Once all animals successfully met conditioning criteria and completed CIE 
exposure, they were re-exposed to the fear associated environment and cues to 
induce fear memory recall. Directly after this session, the IfL was inhibited during 
the memory reconsolidation phase and animals were subsequently exposed to five 
extinction training sessions during which freezing to the CS was recorded. A main 
affect was observed with regards to treatment in male animals (Figure 4-7A, F (3, 
120) = 11.53, p < 0.0001), but an analysis of multiple comparisons revealed that 
this treatment effect was specific to CIE animals who exhibited heightened freezing 
when compared to the air group throughout extinction training. Unlike PrL inhibition 
groups, there were no significant differences recorded in freezing throughout 
extinction when comparing the CIE-I and CIE-NI groups. This effect was also 
absent in female animals, where there was a significant impact of CIE exposure (F 
(3, 120) = 5.249, p = 0.0019), but there were no significant differences between 
the CIE-I and CIE-NI groups (Figure 4-7B). Essentially, while inhibition of the PrL 
during fear memory reconsolidation was able to prevent CIE induced deficits in 
extinction learning, IfL inhibition during fear memory recall in CIE exposed animals 
did not alter freezing behavior.  
 






Following extinction, animals were permitted a three-week break before 
being tested for the spontaneous recovery of freezing behavior following exposure 
to the fear-related cues and context. For male animals, there was a significant 
effect of treatment (Figure 4-8A, F (3, 20) = 3.573, p = 0.0323), but multiple 
comparisons analysis revealed that the only significant difference was between the 
CIE and Air groups (p = 0.0258). Importantly, there was no difference in freezing 
to the CS between the CIE-I group and the CIE-NI group. Additionally, for female 
animals, there were no significant differences between any treatment groups in 
freezing to the CS during the spontaneous recovery testing session (Figure 4-8B, 
F (3, 20) = 0.9874, p = 0.4187). Following the completion of the behavioral 




experiments, animals were transcardially perfused and brains were collected for 









These studies conclude that inhibition of the PrL following fear memory 
recall blocks fear memory reconsolidation and, thus, facilitate the extinction of fear 
behaviors and reduce freezing during spontaneous recovery. This was shown to 
be observed in both male and female animals and was specific to the PrL cortex 
since repetition of the experiment targeting the IfL cortex instead did not induce 
the same behavioral response. The rodent model of comorbid PTSD/AUD used in 
these studies also served to replicate and confirm previous studies completed in 
our lab that explored deficits in fear learning following binge-like ethanol exposure 
(Smiley et al. 2020). These experiments provide preclinical evidence that 
alterations of activity in the prelimbic cortex can serve to alter the presentation of 
fear behaviors during extinction learning and spontaneous recovery in both males 
and females. Additionally, these studies support the hypothesis that manipulation 
of signaling in these regions could serve as a viable treatment option for individuals 
with PTSD/AUD.  
Previously, work in our lab has thoroughly investigated the role of the PrL 
and IfL cortices in the expression and suppression of alcohol seeking behavior 
(LaCrosse et al. 2015, Gass et al. 2014a, b, Gass et al. 2017, Gass et al. 2013). 
Briefly, these studies focused on positive allosteric modulation of the PrL and IfL 
cortices to treat the structural and functional deficits that occur as a result of chronic 
alcohol exposure. These experiments also examined the behavioral impairments 
that can occur as a result of chronic ethanol, including impaired extinction of drug-
seeking behaviors induced by plasticity changes in these regions. Due to the 




additional function of the PrL and IfL in the expression and suppression of fear-
related behaviors (Hayen et al. 2014, Goode et al. 2019, Peters et al. 2009, 
Moorman et al. 2015, Palombo et al. 2017), current work has focused on 
manipulation of these regions to treat co-occurring PTSD and AUD. For these 
experiments, animals are exposed to fear conditioning paradigms before CIE 
exposure to translationally model the progression of these comorbid disorders. 
Essentially, this design allowed us to model the human pattern of trauma exposure 
followed by binge-like levels of ethanol used to self-medicate anxiety symptoms 
while fear extinction training modeled the exposure-type therapies used in human 
psychiatric treatment for PTSD/AUD. Recently, we demonstrated the ability of 
chronic alcohol exposure to cause deficits in fear extinction learning and used 
glutamatergic manipulation of IfL during fear extinction to treat these deficits 
(Smiley et al. 2020). The present experiments expanded upon these data by using 
optogenetics to manipulate prefrontal glutamatergic activity during fear memory 
recall to affect extinction learning instead of during active extinction learning. 
These results add to the established literature regarding differential roles for the 
PrL and IfL cortices and incorporate a novel aspect by using a comorbid model of 
PTSD/AUD in both male and female animals.  
While clinical examinations of PTSD rely on a variety of symptoms that are 
verbally described, such as re-experiencing the trauma, nightmares, and intrusive 
thoughts, we cannot rely on these same diagnostic criteria in animal models (Miao 
et al. 2018). As such, using a preclinical model introduces a variety of limitations 
that need to be addressed. To utilize a valid model of PTSD, we have to rely on 




the underlying neural circuitry that is involved in fear behaviors, behavioral 
responses that are shared between humans and rodents, and the establishment 
of the disorder through exposure to a fixed experience of extreme stress 
(Flandreau et al. 2017). With regard to specific preclinical PTSD models, the model 
must allow for longitudinal studies of symptomology to assess long term responses 
to fear stimuli, be induced by exposure to an aversive event with only a short 
duration necessary to invoke PTSD-like symptoms, and increasing intensity of the 
stimulus must be able to increase the severity of the outcomes (Siegmund and 
Wotjack 2006). Established preclinical models of PTSD include restraint stress, 
single prolonged stress, social defeat stress, and fear conditioning. While each of 
these models has aspects that meet the above criteria, fear conditioning is the 
model that best allows us to answer questions regarding longitudinal relationships 
between the alcohol exposure and fear related learning and memory  (Ursano et 
al. 2007, Borghans et al. 2015, Lissek et al. 2015, Singewald et al. 2019, Mahan 
et al. 2012, Amstadter et al. 2009). While our preclinical model of PTSD/AUD 
achieves validity, there are additional limitations that need to be considered when 
examining these data. First, all extinction training was completed relatively close 
to the completion of ethanol exposure. The literature regarding the effects of 
ethanol on fear learning have been mixed with regards to both the level of ethanol 
exposure that is required to induce changes in fear learning as well as any long-
term effects induced by ethanol (Holmes et al. 2012, Quiñones-Laracuente et al. 
2015). As such, an important aspect of future studies would be to include groups 
that receive extinction training at a later date to assess the long-term effects of 




ethanol exposure on fear learning. An additional limitation comes from the fact that 
estrous cycle was not examined in the female treatment groups. While estrous 
cycle has been shown to alter behavior in certain preclinical models of addiction 
(Lacy et al. 2016, Anker and Carroll 2011) and cognition (Cordeira et al. 2018, 
Broestl et al. 2018), data from both our lab (Smiley et al. 2020) and others (Maeng 
et al. 2015) establishes the fact that estrous cycle phase does not have an effect 
on freezing behavior during extinction. Therefore, we do not see estrous cycle as 
a factor that could serve to alter fear behaviors during extinction in these studies.  
Taken together, the results from these experiments conclude that inhibition 
of the PrL, and not the IfL, during fear memory reconsolidation facilitates extinction 
learning and prevents increased freezing during memory reconsolidation for both 
male and female animals in a preclinical model of PTSD/AUD. These studies 
support the use of modulation of memory reconsolidation for the treatment of 
learning and memory deficits that occur as a result of exposure to stress and 
chronic alcohol and, further, identify specific time-points and brain regions that are 
















ADOLESCENT THC AND ETHANOL EXPOSURE LEADS 






Background and Significance 
Cannabis use disorder (CUD) has doubled in prevalence over the past 
decade as marijuana becomes increasingly accessible due to a country-wide trend 
towards legalization. As a result, marijuana is the most commonly used illicit drug 
in the United States. Importantly, levels of Δ-9-tetrahydrocannabinol (THC), the 
psychoactive component of the drug, have also steadily increased in recent years. 
Studies have found that cannabis use has grown the most in the adolescent 




population, a group that is increasingly at risk for harmful side-effects of drug use 
due to ongoing brain maturation, most notably in the prefrontal cortex (PFC). This 
region is involved in both addiction and anxiety disorders that can result from 
neurochemical changes due to trauma experience or insults from chronic drug use. 
These alterations often lead to cognitive deficits that maintain and reinforce both 
disorders. Clinical studies have found that the age of onset of marijuana use is 
positively correlated with the development of both CUD as well as long-term 
impairments in cognition. The main deficits examined in this patient population 
include behavioral inflexibility and propensity towards both risky and impulsive 
behaviors. These deficits are common to both substance use disorders and anxiety 
disorders and serve as barriers to successful treatment outcomes. Increasing 
evidence indicates that CUD often occurs along with other debilitating conditions 
including both alcohol use disorder (AUD) and anxiety disorders such post-
traumatic stress disorder (PTSD). These disorders have also been shown to 
induce similar cognitive deficits that could add to the deleterious effects of chronic 
cannabis exposure. The average age at which CUD develops is around late 
adolescence to early adulthood, a period in which brain development, especially 
in prefrontal regions, is still progressing (Khoury et al. 2010). Surveys of high 
school seniors determined that half of them have tried marijuana while 5% of them 
participate in daily use (Schweinsburg et al. 2008). Adolescents who begin 
marijuana use earlier, and adult users who started use in mid-adolescence, have 
more problems with cognition even following the cessation of marijuana use. 
Studies completed in both animals and humans indicate that chronic marijuana 




exposure causes a greater vulnerability to developing abnormalities in cognition 
(Schweinsburg et al. 2008, Pope et al. 2003, Patton et al. 2002, Irimia et al. 2015, 
Hill et al. 2006). There is consensus in the literature that, when comparing early 
vs. late onset cannabis use, those that started using cannabis earlier in life during 
adolescence exhibit poorer cognitive performance than those that started using 
cannabis later and those that did not use cannabis (Pope et al. 2003). Interestingly, 
there has also been associations found between long term cannabis use and 
higher rates of developing anxiety and depression later in life, especially for 
females who begin drug use in adolescence (Patton et al. 2002). While the acute 
effects of cannabis use on cognition are established, there is less data that 
examines long term effects on cognitive processing. Studies using animal models 
are also scarce, but there is some evidence that long term exposure to THC can 
cause motor impulsivity and perseveration, hallmarks of behavioral disinhibition 
and impaired cognitive flexibility (Irimia et al. 2015). Other models that have used 
CB1 agonists have found decreased behavioral flexibility in a model of strategy set 
shifting (Hill et al. 2006). While the presence of cognitive deficits is being explored 
in the clinical population, there is further research needed to determine the 
mechanism by which these deficits are induced to develop new targets for 
pharmacological treatments. Therefore, these studies examined the impact of THC 
vapor exposure and chronic intermittent ethanol exposure (CIE) as a model of co-
occurring cannabis and alcohol use during adolescence on prefrontal cortex reliant 
behaviors. Following adolescent exposure to THC/ethanol, animals were tested for 




deficits in cognition and alterations in fear and alcohol seeking behaviors were 
addressed with the use of N-acetylcysteine as a pharmaceutical treatment.  
 
Materials and Methods  
Animals 
Male Wistar rats were postnatal day (PD) 35 for adolescents and PD 55 for 
adults upon arrival (Charles River Laboratories) and were pair housed in standard 
cages in a vivarium that maintained a reverse light-dark cycle. Lights were turned 
off at 0900 and this allowed for behavioral testing to occur during the dark phase. 
Animals received continuous access to food and water except during behavioral 
testing which occurred for up to one hour per day. All experiments had prior 
approval by the Institutional Animal Care and Use Committee at the Medical 
University of South Carolina and were completed within guidelines set forth by the 
National Research Council’s Guideline for the Care and Use of Mammals in 
Neuroscience and Behavioral Research (2003). A total of 88 animals were used 
across Experiments 1 and 2, and the treatment groups were assigned based on 
the outline in Table 5-1.  






Adolescent THC Vapor Exposure 
 THC vapor exposure started at PD 40 for adolescent animals and PD 60 
for adults. The method of vapor administration occurred according the protocol 
previously established by Spencer et. al. 2018. During each exposure session, 
animals received a total of 20 minutes of vapor exposure per day for 5 days. Out 
of the total 20 minutes, each THC exposure session is broken up in the following 
manner to keep THC concentrations steady: in the morning there were two 5-
minute exposures followed by a three-hour break and two additional 5-minute 
exposures. The solution vaporized during each exposure session consisted of 
THC at a concentration of 200 mg per mL of ethanol and CBD at 20 mg per mL of 
ethanol. These solutions are mixed at a 1:1:1 ratio with glycerol to obtain a final 
solution containing THC and CBD at a ratio of 10:1. A Volcano (Storz and Bickel, 
Oakland, CA) was used to vaporize 150 uL of the THC/CBD solution and the 
resulting vapor was administered equally among the animals. Animals assigned to 
the NAC treatment groups received an intraperitoneal (IP) injection of the drug 




immediately following each exposure session. Following the five total days of THC 
exposure, animals were permitted a two-day break before entering chronic 
intermittent ethanol exposure (CIE). 
 
Chronic Intermittent Ethanol Exposure (CIE) 
Chronic intermittent ethanol exposure (CIE) is a model of binge-like alcohol 
consumption that uses repeated cycles of ethanol vapor exposure and abstinence. 
This procedure started at ~PD 47 for animals in Experiment 1 and consisted of 
four nights of vapor exposure from 1800-0800 (14 hours on/10 hours off) followed 
by a two-day break, and this cycle was completed a total of two times. Intoxication 
levels were graded on a five-point scale that judges the level of intoxication based 
on motor behavior. Rats were scored based on the following behaviors: 1: no signs 
of intoxication and no motor impairment, 2: slight intoxication and slight motor 
impairment, 3: moderate intoxication with obvious motor impairment but retains the 
ability to walk, 4: loss of righting reflex, highly intoxicated, 5: loss of righting reflex 
and eye blink reflex, extremely intoxicated (Nixon and Crews, 2002). The goal of 
each CIE session was to reach moderate intoxication levels which corresponds to 
a 2-3 on the five-point scale and ~250 mg/dl BEC. Animals in treatment groups 
that received NAC received injections two hours before going into the CIE 
chambers at night and immediately after they came out of the chambers in the 
morning.  




Strategy Set-Shifting Task 
To study the effect of adolescent THC and ethanol exposure on behavioral 
flexibility in adulthood, Experiment 1 utilized a strategy set-shifting paradigm 
following the techniques established by Stan Floresco (Floresco et al. 2008). To 
establish lever pressing behavior, there were a total of five training phases prior to 
the set-shifting test. First, Phase1A consisted of both levers being presented and 
a press on either lever would result in the delivery of 10% sucrose. Once all 
animals were able to perform ~50 lever presses within this 30-minute session, they 
were able to move onto Phase1B (~10 days of training). This phase was identical 
to Phase 1A with the addition of retraction of the levers following each lever press. 
Again, animals had to maintain ~50 lever presses during these session before 
moving on the Phase1C (~8 days of training). Phase1C built upon 1B by presenting 
the retractable levers for ten second intervals. If animals did not press the lever 
within the ten seconds, levers were retracted, and the trial restarted. Animals were 
able to move on from Phase1C once they finished the session with less than 10 
omissions (~10 trials). Animals were then tested for a side preference for the test 
session to be completed using the opposite lever. The following two phases 
involved pressing a specific lever according to a trained rule to determine changes 
in cognitive flexibly when the rule was changed between sessions. Rule 1 was 
established in PhaseCue, during which animals were required to respond to the 
lever that was cued by illumination of the associated stimulus light. Criteria for 
learning this rule was met when all animals press 8 times in a row correctly in a 




minimum of 30 trials. These experiments tested a between-session set-shift, so, 
once criteria was met for the first rule, the session on the following day was under 
a second rule. The second rule required the animals to press on a single lever 
location regardless of where the light appears. Two days of testing were 
administered using this criteria, and animals were eliminated from the experiment 
if they did not meet criteria within this time period. Two different types of errors, 
perseverative and regressive, were recorded to determine if the ability to either 
shift to new strategy or maintain the new strategy was affected by drug exposure. 
Perseverative errors were those that occur before the animal has made five correct 
presses under the second rule while regressive errors are those that occur after 
five correct presses have been made. Animals that take longer to learn the second 
rule and make more errors that cause them to continue responding for the original 
rule are those considered to have impaired behavioral flexibility. 
 
Operant Ethanol Self-Administration  
For Experiment 2, operant self-administration paradigms were used to 
determine the effects of adolescent THC exposure on ethanol seeking during 
adulthood. Following THC exposure, animals were placed into operant chambers 
and trained to lever press for 20% ethanol on an FR-1 schedule of reinforcement. 
These self-administration sessions each lasted one hour and occurred three days 
a week. Each lever press on the active lever delivered 20% ethanol v/v in water 
accompanied by stimulus light illumination and tone presentation (2900 Hz, 65 dB) 




and was followed by a 4-second timeout period during which presses were 
recorded but did not lead to reinforcer delivery. Once response criteria of 30 lever 
presses was met (~10 sessions), ethanol concentration was lowered to 10% and 
criteria of 60 lever presses was met (~15 sessions). Animals completed extinction 
training following the completion of self-administration. During extinction sessions, 
pressing on the active lever allowed for stimulus light illumination and tone 
presentation in the absence of any ethanol reinforcer. Extinction criteria was met 
when lever pressing for each rat was reduced to 80% of the lever presses recorded 
on last two days of self-administration training (~5 sessions). Once lever pressing 
was extinguished, there was a break period of 21 days following which 
spontaneous recovery of lever pressing behavior was tested in a single session 
where lever presses were recorded across the 30-minute session and resulted in 
cue presentation alone.  
 
N-acetylcysteine (NAC) Preparation 
For animals in the NAC treatment group across both experiments, NAC was 
delivered at a dose of 100 mg/kg intraperitonially (IP) and was prepared on the day 
of injection following previously published methods (Garcia-Keller et al. 2019). To 
achieve this concentration, 5 grams of NAC (Millipore Sigma) was added to 5 mL 
of 27 mg/mL NaOH in 0.9% saline. Since this solution is acidic, 200 mg/mL NaOH 
in saline was added in 50 uL increments until the solution reached a pH of ~7.5. 
On the day of injection, animals were weighed and dosed accordingly.  





Statistical Analyses  
These behavioral data were analyzed using SPSS version 23.0 software 
(SPSS Inc., Chicago, IL) and Prism version 8 (GraphPad software, La Jolla, CA). 
All experiments used an n of 8 animals/treatment group, and a p value of less than 
0.05 was considered statistically significant. The primary dependent variable 
measured for Experiment 1 was either infusions received, well entries completed, 
or average lever pressing for each of the training and test phases. Behavioral data 
from Phase1A-1C, Side Preference, and Phase Cue trials were analyzed using a 
2-way ANOVA with Holm-Sidak multiple comparisons as the post-hoc test used to 
determine differences between each treatment group. Trials completed in the set-
shifting test were analyzed using an ordinary one-way ANOVA with Holm-Sidak 
multiple comparisons test used to compare all five treatment groups while errors 
made during this test were analyzed through a 2-way ANOVA with a Holm-Sidak 
multiple comparisons test. For Experiment 2, lever pressing behavior throughout 
self-administration, extinction, and spontaneous recovery were analyzed using a 
2-way ANOVA with a Holm-Sidak multiple comparisons test to compare across 
treatment groups. Animals in Experiment 1 were eliminated from the experiment if 
they did not meet criteria of 10 correct lever presses within these two set-shifting 
testing sessions. Additionally, animals were eliminated from Experiment 2 if they 
did not meet self-administration criteria during the second phase of acquisition 
where ethanol concentration was at 10%.  





Two main experiments were completed to determine the effects of 
adolescent exposure to THC and ethanol on prefrontal cortex reliant behaviors 
including cognitive flexibility and drug seeking. Generally, animals across all 
experiments were exposed to THC vapor during mid-adolescence prior to 
behavioral testing across these two behavioral paradigms to widely assess 
behavioral responses to prefrontal cortex reliant tasks.  
 
Effects of adolescent THC and ethanol exposure on cognitive flexibility  
 Experiment 1 was comprised of 40 male animals across the following 
treatment groups: Air exposed controls, THC exposed, CIE exposed, both THC + 
CIE exposed, and THC + CIE exposed animals that also received NAC (n = 
8/group). Following the design outlined in Figure 5-1, animals were first exposed 
to THC vapor for a total of five days in which animals in the NAC treatment groups 
received injections directly after each exposure session. THC concentrations in the 
blood using this method of vapor administration has previously been established 
(Spencer et al. 2019) and, thus, was not obtained for these experiments.  
 






CIE exposure commenced following the completion of THC exposure and 
behavioral intoxication ratings were taken following each night of exposure to 
confirm that animals were maintaining a moderate level of intoxication throughout 
the procedure (Figure 5-2). Animals were exposed to a total of eight nights of CIE 
vapor exposure with a goal of a behavioral intoxication rating of ~2-3 which 
corresponds to a blood ethanol concentration of ~250 mg% (Gass et al. 2016, 
Smiley et al. 2020).  






THC and CIE treated animals sought increased amounts of sucrose during set-
shifting training  
Set-shifting training commenced two days following the completion of CIE, 
and lever pressing for sucrose was monitored throughout all five training phases. 
During Phase1A animals were required to press either the right or left lever to 
receive a sucrose reward and trials continued daily until all animals met a criteria 
of ~50 lever presses within the 30-minute session. There was a significant effect 
of treatment on the number of infusions received and the number of well entries 
performed throughout Phase1A, with THC+CIE animals as well as animals 
exposed only to CIE  exhibiting increases in sucrose seeking (Figure 5-3A) [F (4, 
70) = 15.0, p < 0.0001]. Following Phase1A, animals were trained on retractable 




levers in Phase1B where both levers were retracted following each lever press. 
Increases in sucrose seeking were observed in drug treated animals in this phase 
as well [F (4, 70) = 3.795, p = 0.0075], where THC+CIE and CIE treated animals 
performed more well entries than control groups while the number of infusions that 
were received remained similar between the groups (Figure 5-3B). This trend 
continued throughout Phase1C, where animals were trained to ten-second 
presentations of the levers. A similar effect was observed, where CIE exposed 
animals maintained an increased numbers of infusions as well as well entries 










These first three phases trained animals to lever press to receive sucrose 
in a manner that was specific to a ten-second availability followed by lever 
retraction. Next, animals were tested in a side-preference test to determine if they 
preferred either lever location. This test found that all animals exhibited a right lever 
preference (Figure 5-4A) and, thus, all subsequent testing used a left lever active 
program for the results not to be skewed by any innate lever preference. The final 
training phase of the set-shifting task was PhaseCue in which animals were trained 
to press either the right or left lever in response to an illuminated stimulus light that 
appeared above the lever. All animals had to press the indicated lever 8 times in 
sequence in a maximum of 30 trials to move on from this phase, and, while this 
criteria was the same between the groups and all animals received the same 
amount of reinforcers, those previously exposed to both THC+CIE performed more 
well entries for sucrose during this session [F (4, 70) = 4.786 p = 0.0018] (Figure 
5-4B).  
 




Animals exposed to THC and CIE during adolescence display impairments in 
cognitive flexibility  
Once these five training phases were completed, animals were tested on a 
between session set-shift to measure cognitive flexibility. During this test, animals 
were required to only press the left lever regardless of where the stimulus light was 
illuminated. The number of trials required for animals to learn this new rule and the 
number of perseverative and regressive errors that were performed when animals 
made an incorrect lever choice were recorded during this test. These studies found 
that THC+CIE exposed animals took an increased number of trials to meet criteria 
during the set-shifting test [F (4, 29) = 3.615, p = 0.0165], and that the increase 
was due to these animals performing more perseverative errors, or errors that 
occurred prior to successfully completing five correct lever presses (p = 0.0135), 
both of which indicate that THC+CIE exposed animals exhibit impairments in 
cognitive flexibility (Figure 5-5B). Additionally, this increase in both trials to criteria 
as well as perseverative errors was prevented by NAC treatment in THC+CIE 












Effects of adolescent THC exposure on ethanol seeking in adulthood 
Experiment 2 was completed using 48 male animals within the following 
treatment groups: Adolescents: THC, Air, THC+NAC, Adults: THC, Air, THC+NAC 
(n = 8/group). This experiment utilized the design outlined in Figure 5-6 where 
animals were exposed to THC vapor for a total of five days and those in the NAC 
treatment groups received injections directly following each exposure session. 
Ethanol self-administration began following THC exposure and consisted of a total 
of 30 sessions, the first fifteen in which animals received 20% ethanol followed by 
fifteen subsequent sessions at 10% ethanol. Following successful acquisition of 
self-administration behavior, all animals were put through a week of extinction and 




then a three-week break occurred before animals were tested for spontaneous 




Animals exhibit escalations in ethanol seeking during acquisition and extinction 
when exposed to THC during adolescence, but not adulthood 
 Following exposure to THC during either adolescence or adulthood, 
animals began training in self-administration paradigms. There was a significant 
effect of treatment [F (5, 19.67) = 2.909, p = 0.0398] on lever pressing behavior 
across all of self-administration, with animals exposed to THC during adolescence 
performing a significantly increased number of lever presses when compared to 
air exposed controls (Figure 5-7A). Notably, this effect was not present when THC 




exposure occurred during adulthood. Similarly, this increase in ethanol seeking 
was also observed with regards to the number of reinforcers received throughout 
self-administration [F (5, 22.58) = 3.027, p = 0.0309], and was observed for 











A similar effect was observed during extinction training, where adolescent 
animals exposed to THC performed an increased number of lever presses during 
extinction when compared to air exposed animals [F (2, 102) = 4.943, p = 0.0089] 
(Figure 5-8A), and this was not observed in animals exposed to THC during 




This trend was carried over into spontaneous recovery testing where, while 
there were no effects of THC exposure on lever pressing during spontaneous 
recovery when compared to air exposed animals [F (5, 14.98) = 1.432, p = 0.2692], 
THC exposed adolescents performed more lever presses during this test when 
compared to THC exposed adults (p = 0.0364) (Figure 5-9A).  





   
Discussion 
 In summary, these experiments determined that exposure to THC and CIE 
during adolescence leads to impairments in cognitive flexibly shown by increases 
in trials to criteria as well as perseverative errors in a set-shifting test. Additionally, 
in Experiment 2, we observed that animals exposed to THC during adolescence 
increase ethanol seeking during self-administration, shown by increased lever 
pressing behavior, and that, in general, adolescent animals seek ethanol at an 
increased rate compared to adults. These experiment provide evidence that THC 
exposure during adolescence can have deleterious effects on prefrontal cortex 




reliant cognitive tasks such as set-shifting and drug-seeking, and NAC is able to 
reverse these cognitive deficits.  
 While the data presented support the literature with regards to the effects 
of THC on cognition and drug-seeking behaviors, there are a number of limitations 
that need to be addressed. First, while adult groups were included for the analysis 
of ethanol seeking, no adults were tested in the experiments that involved cognitive 
flexibility testing. Although this is an important group that needs to be included to 
make conclusions regarding the specificity of this effect to the adolescent 
population, the specificity of these effects to the adolescent population is supported 
by previously published literature (Szkudlarek et al. 2019). Additionally, during CIE 
exposure, blood was not taken to test for blood ethanol concentration (BEC) to 
make sure that animals were appropriately intoxicated. From data collected across 
a variety of previous studies (Smiley et al. 2020; Trantham-Davidson et al. 2014; 
Gass et al. 2014a, Gass et al. 2017, Uys et al. 2016), we have determined that a 
behavioral rating of 2-3 will consistently be associated with a BEC of ~200-300 
mg/dl and, thus, did not take samples from these animals. Further, these studies 
did not include a treatment group that received NAC in the absence of any other 
drug treatment. Preclinical studies completed using NAC to reduce neurotoxicity 
have found that NAC treated animals did not differ from controls, and an insult had 
to be present for NAC to impact oxidative injury and inflammation (Abdel-Wahab 
and Moussa 2019). This data is supported by our previous studies using NAC to 
prevent stress induced increases in drug relapse that found control animals treated 




with NAC did not exhibit any behavioral differences (Garcia-Keller et al. 2020). 
Therefore, for these studies, we expect a NAC treated group to exhibit no 
differences in behavioral outcomes when compared to controls.  
 In conclusion, these studies found that adolescent exposure to THC and 
ethanol leads to deficits in prefrontal cortex reliant cognition, including set-shifting 
and drug seeking behaviors. These deficits could potentially be a result of 
impairments in glutamate functioning since NAC treatment led to reductions in 
ethanol seeking and increased cognitive flexibility in THC and CIE exposed 
animals. Further studies are needed to determine the exact mechanism of action 
that these drugs are following to exert these effects, but these studies supply 
valuable information regarding the behavioral effects of adolescent exposure to 


















EXPOSURE TO THC AND ETHANOL DURING 
ADOLESCENCE HEIGHTENS RESPONSES TO FEAR 






Background and Significance 
 Cannabis has become the most commonly used illicit drug that is 
increasingly being used for recreational purposes, with only ~10% of users citing 
use for exclusively medicinal reasons (National Academies of Sciences, 2017). As 
the rate of cannabis use has increased from 4.1% in 2002 to 9.5% in 2013 (Hasin 
et al. 2015) and almost all age groups have shown increases in past-month use 
within this time period (National Academies of Sciences, 2017). The population in 




which heavy use and high intensity use is most prevalent is late adolescence, 
which is also the average age at which CUD is shown to develop (Hasin et al. 
2016). Surveys of high school students reveal that ~50% of seniors have tried 
marijuana while 5% of them participate in daily use (Schweinsburg et al. 2008). 
While CUD itself is associated with adverse consequences, such as deficits in 
cognition and attention, this disorder is also highly comorbid with other substance 
use and psychiatric disorders that further add to these cognitive impairments. 
Clinically, CUD patients are observed to have up to a 10 times greater chance of 
developing alcohol use disorder (Hasin et al. 2015) and that ~80% of those with 
CUD also have AUD (Hasin et al. 2016). This comorbidity is also present for CUD 
and post-traumatic stress disorder, where CUD leads to a greater chance of 
developing PTSD and, conversely, PTSD leads to higher rates of cannabis abuse 
as well (Yarnell et al. 2015). This is especially true for the adolescent population, 
in which marijuana is the most commonly used illicit substance by adolescents with 
PTSD, and an adolescent with PTSD also has a two-fold increase in the likelihood 
of developing CUD (Bujarski et al. 2012). Exposure to trauma also increases 
alcohol use, especially when it occurs during adolescence, a period in which there 
are already high rates of binge drinking (Khoury et al. 2010). While the comorbidity 
between CUD with AUD and PTSD is extremely clinically relevant, there has been 
a lack of pre-clinical research into the underlying brain mechanisms that contribute 
to the maintenance and treatment of these co-morbid disorders. Therefore, in 
these experiments, we examined the impact of adolescent exposure to cannabis 




and alcohol on responses to fear stimuli and sought to determine the underlying 
signaling changes responsible for these alterations.  
 
Materials and Methods 
 
Animals 
Male Wistar rats were Postnatal Day 28 and ~100 grams on arrival and 
were individually house in standard polycarbonate cages. Animals were permitted 
one week to habituate to a 12/12 reverse light-dark cycle with lights off at 0900, 
allowing for behavioral testing to occur during the dark phase of the cycle. All 
experiments had prior approval by the Institutional Animal Care and Use 
Committee at the Medical University of South Carolina and were completed within 
guidelines set forth by the National Research Council’s Guideline for the Care and 
Use of Mammals in Neuroscience and Behavioral Research (2003). A total of 88 
animals were used for this experiment and were broken up into the following 
treatment groups: Air, THC, CIE, THC+CIE, THC+CIE+NAC (n = 16/group). A 
subset of animals from each group (n = 8/group) received surgical implants to 
monitor brain activity during these behavioral paradigms (n = 8/group). A 
supplemental group was added that only received NAC treatment in the absence 
of all other drug manipulations and was only tested on the behavioral aspects of 
this experiment (n = 8). The general outline of the experimental design for these 
studies is outlined in Figure 6-1.  






Surgical Procedures  
For the subset of animals used to analyze brain signaling in response to 
fear conditioning, fiber photometry was used to measure calcium transients 
induced by neuronal signaling in real time during behavioral testing. Animals were 
injected with a virus containing genetically encoded calcium indicators to be used 
as a correlative measure of neural activity. Surgeries occurred between PD 35-36 
and were followed by a one-week recovery period. Rats were anesthetized using 
vaporized isoflurane and oxygen (flow rate of 0.4 L/min, 5% for induction and 2.5-
3.5% for maintenance) and were mounted in a stereotaxic apparatus once fully 
under (Kopf Instruments, Tujunga, CA). An adeno-associated virus encoding 




GCaMP6f with a promoter for CaMKII (AAV1-CaMKII-GCaMP6f, AddGene, 
Watertown, MA) was injected into the prelimbic cortex (PrL) using a microsyringe 
(Hamilton Company, Reno, NV) at a volume of 300 nL and a rate of 1 nL/s. The 
PrL coordinates used in these surgeries were based on pilot experiments that used 
dye injections to optimize the PrL location in PD 35 animals (in mm from bregma 
and the skull surface, anterior/posterior +3.2, medial/lateral ± 0.6, and 
dorsal/ventral −2.8). There was a ten-minute period allowed for virus infusion 
following injection,. A handmade optical fiber probe (400 μm diameter patch cord 
in a 2. 5 mm ferrule, Thorlabs) was then implanted at the same coordinates. Two 
stainless steel screws were mounted in the skull and were covered in dental 
cement to keep the probe in place. The surgical incision was treated with 2% triple 
antibiotic ointment and 2% xylocaine directly after surgery and antibiotic ointment 
was applied as needed in the following days. Additionally, the following drugs at 
the listed doses were administered to each animal directly following surgery: 
ketorolac (body weight/1000), dexamethasone (body weight/1000), and saline 
(body weight/100) cefazolin (1/2 body weight/100). For post-operative care, 
ketorolac was used for pain management and delivered the day following surgery 
with cefazolin antibiotic administered for two days following surgery.  
 
Adolescent THC Vapor Exposure 
Once animals were allowed one week for surgical recovery, exposure to 
THC vapor occurred following the method established by Spencer et. al. (2018). 




Starting at PD 40, each animal received a total of 20 minutes of vapor exposure 
per day for 5 days. Each THC exposure session was broken up into 5-minute 
administrations, with two in the morning and two in the afternoon following a three-
hour break, to keep THC concentrations steady. Each exposure session used a 
vaporized solution consisting of THC at a concentration of 200 mg per mL of 
ethanol and CBD at 20 mg per mL of ethanol. These solutions were mixed at a 
1:1:1 ratio with glycerol to obtain a final solution containing THC and CBD at a ratio 
of 10:1. Aliquots of 150 uL of this solution were vaporized using a Volcano (Storz 
and Bickel, Oakland, CA) and the resulting vapor was administered equally among 
the animals. If animals were assigned to the NAC treatment group, they received 
intraperitoneal (IP) injections of the drug immediately following both the morning 
as well as the afternoon session. Following the five total days of THC exposure, 
animals were permitted a two-day break before entering chronic intermittent 
ethanol exposure (CIE). 
 
Chronic Intermittent Ethanol Exposure (CIE) 
CIE commenced on PD 50 and was used to model binge-like alcohol 
consumption using repeated cycles of ethanol vapor exposure and abstinence. 
This paradigm consisted of four nights of vapor exposure from 1800-0800 (14 
hours on/10 hours off) followed by a two-day break, and this cycle was completed 
a total of two times. A five-point behavioral scale was used to grade intoxication 
levels based on motor behavior. Rats were assigned the following scores based 




on behaviors exhibited when taken out of the chambers in the mornings: 1: no 
signs of intoxication and no motor impairment, 2: slight intoxication and slight motor 
impairment, 3: moderate intoxication with obvious motor impairment but retains the 
ability to walk, 4: loss of righting reflex, highly intoxicated, 5: loss of righting reflex 
and eye blink reflex, extremely intoxicated (Nixon and Crews, 2002). An 
intoxication rating of 2-3 was the goal of each CIE session which corresponds to a 
blood ethanol concentration (BEC) of ~250 mg/dl. Animals in the NAC treatment 
group received injections two hours prior to CIE exposure and immediately after 
they came out of the chambers in the morning.  
 
N-acetylcysteine (NAC) Preparation 
NAC was administered at a dose of 100 mg/kg and was prepared on the 
day of injection. This dose was chosen to optimize the effects of NAC on the 
glutamate system based on previous experiments (Garcia-Keller et al. 2019). To 
achieve this concentration, 5 grams of NAC (Millipore Sigma) was added to 5 mL 
of 27 mg/mL NaOH in 0.9% saline. Since NAC is acidic, 200 mg/mL NaOH in saline 
was added in 50 uL increments until the solution reaches ~pH 7.5. On the day of 
injection animals were weighed and dosed accordingly and injections were 
delivered intraperitonially (IP). 
 
 




Fear Conditioning Procedure 
Two days following the end of CIE exposure, fear conditioning was used to 
determine differences in behavioral responses to fear stimuli and followed 
previously published methods (Cain et al. 2002, Holmes et al. 2012, Izquierdo et 
al. 2006, Sinclair et al. 2012, Wellman et al. 2007). This paradigm consisted of 
exposure to multiple tone/shock pairings to measure behavioral responses to the 
tone over time and between treatment groups. Each trial lasted approximately five 
minutes each and occurred once a day for three days total. Conditioning sessions 
consisted of an initial 120 second acclimation period followed by the presentation 
of four tones (80 dB, 3 kHz) separated by a 10 second inter-stimulus interval. Each 
tone was paired with a 0.75 mA shock that occurred during the final two seconds 
of the tone. Animals were presented with a total of 12 tone/shock pairings across 
three separate days. Trials were recorded and analyzed using AnyMaze software 
to determine freezing behavior (Stoelting Co. Wood Dale, IL). 
 
Calcium Imaging  
 In the subset of animals previously implanted with fiber optic probes, 
calcium imaging was performed using a custom-built fiber photometry rig based 
on the design of the Deisseroth (Lerner et al. 2015) and Woodward labs 
(Braunscheidel et al. 2019). A LED driver (Thorlabs) provided both 405 nm and 
490 nm illumination which were combined in a fluorescence mini-cube (Doric 




Lenses). A custom made 400 μm diameter patch cord terminating in a ceramic 
sleeve was used to connect the mini-cube to the animal’s fiber optic implant. 
Synapse software (TDT) was used to control a digital processor (TDT) that 
received input from a photodetector (Newport) that collected emission signals at 
both 405 nm and 490 nm. Integrated TTL signals were used to time-lock signals 
with the start of each fear conditioning session as well as the presentation of each 
tone throughout the session. Custom-written MatLab codes (MathWorks) were 
used to analyze these data. Signals from the 405 and 490 nm channels were 
subtracted from each other to calculate data as ΔF/F. Data for each testing day 
was then z-normalized to a combined baseline of all signaling across the whole 
session for that day.  
 
Tail Immersion Test 
 Following the completion of all behavioral testing, animals in the surgical 
subset groups were exposed to a tail immersion test to test for differences in pain 
sensitivity between the groups. Prior to the test day, all animals were habituated 
to handling and immersion using room temperature water. Additionally, each 
animals’ tail was marked 3 cm above the tip to standardize immersion length. On 
the day of the test, water was heated to 52°C and kept constant for each animal. 
The tail was dipped into the water to the 3 cm mark and animals were held into the 
water until their tail broke the surface. This was repeated for a total of three times 
per animal in succession and immersion time was averaged across the three tests 




for each animal. This test was recorded and manually scored to determine average 
immersion time for each animal and averaged across treatment group.  
 
Statistical Analysis  
Behavioral experiments included 12-16 animals per treatment group while 
signaling data comprised 6-8 animals per group. The variation in sample size was 
a result of the following exclusion criteria. Animals were eliminated from behavioral 
experiments if they were not freezing over 50% of the time in response to the tone 
on Conditioning Day #3 and from signaling experiments if the fiber optic probe did 
not terminate above the virus in the prelimbic cortex. Data were analyzed using 
Prism version 8 (GraphPad software, La Jolla, CA) and a p value of less than 0.05 
was considered statistically significant. Fear conditioning data were analyzed 
using a 2-way ANOVA with Holm-Sidak multiple comparisons as the post-hoc test 
used to determine differences between each treatment group. Signaling data was 
analyzed using a 1-way ANOVA with post-hoc testing completed using a Holm-




CIE exposure resulted in moderate levels of intoxication that were comparable 
between the groups 




 Behavioral intoxication ratings were complimented with blood ethanol values 
to assess the level of intoxication for all CIE exposed animals across the three 
ethanol exposed treatment groups. All animals achieved a moderate level of 
intoxication with behavioral ratings of between 2-3 (Figure 6-2A) and BEC levels 
of between 300-400 mg/dL (Figure 6-2B). Additionally, animals’ weights were 
taken during each phase of the experiment to maintain health between the 
groups, and there were no differences in weight between treatment groups 
throughout the experiment (Figure 6-2C).  
 
 




Adolescent exposure to THC and CIE increases behavioral responding to fear 
stimuli during conditioning  
 When conditioning behavior is examined as an average of percent freezing 
during the tones per each conditioning day, there was a significant effect of 
treatment [F (5, 215) = 12.81, p < 0.0001] such that THC+CIE and THC exposed 
animals exhibited an increased freezing response to the tones on Conditioning 
Day #2 when compared to all other treatment groups (Figure 6-3A). Additionally, 
this effect carried over to Conditioning Day #3, where drug treated groups exhibited 
heightened levels of freezing when compared to air treated controls as well as 
THC+CIE exposed animals that also received NAC treatment concurrent with each 
drug exposure (Figure 6-3A). During each conditioning day, animals received a 
total of four tone/shock pairings and, thus, freezing to each individual tone 
presentation were examined to determine when responses began to differentiate 
between the groups. There was a significant effect of treatment in individual tone 
responses [F (5, 860) = 27.66, p < 0.0001], with drug treated animals exhibiting a 
consistent increase in freezing when compared to control and NAC treated animals 
(Figure 6-3B). When comparing THC+CIE exposed animals vs. controls and NAC 
treated animals, the initiation of this effect was in response to tone presentation #6 
on Conditioning Day #2 where these animals began exhibiting a significant 
increase in freezing to the tone (Figure 6-3B, p = 0.0274 vs. Air, p = 0.0059 vs. 
THC+CIE+NAC). 











Increased freezing during conditioning is not associated with alterations in pain 
tolerance 
 Following the completion of behavioral testing, all animals were exposed to a 
tail immersion test to ensure that behavioral responding during conditioning was 
not due to drug-related changes in pain sensitivity. There were no differences 
observed between any of the treatment groups in average immersion time during 
the tail immersion test designed to determine pain sensitivity (Figure 6-4) [F (4, 
25) = 0.03744, p = 0.9971]. 
 
 




THC and CIE exposure results in a freezing associated increase in prelimbic 
signaling in response to the shock during conditioning   
 In addition to the behavioral measures taken during fear conditioning, a subset 
of animals in each treatment group received fiber optic implants to measure 
signaling from the prelimbic cortex during each session. While signaling data was 
recorded throughout the session, the most variation in signaling was observed in 
response to each shock presentation and, therefore, this is the data focused on in 
this section. Each figure displays averaged signal from the prelimbic cortex across 
animals between each treatment group from the five seconds prior to each shock 
and five seconds following each shock, with the red mid-lines reflecting shock 
onset. On Conditioning Day #1, while most groups exhibit an increase in PrL 
activity following the shock, the magnitude of this difference differs between the 




























 The magnitude of the PrL response to the shock is shown to differ between the 
groups when the difference in signal prior to vs. following the shock is quantified 
per each treatment group (Figure 6-6). In response to all four shock presentations 
on Conditioning Day #1, THC+CIE treated animals exhibit a heightened PrL 
response to the shock when compared to air exposed controls.  
 
 Further, signaling from Conditioning Day #3 reflects conditioned responding 
while shock responses on Conditioning Day #1 reflect responses during early 
phases of conditioning when animals have not yet formed a conditioned response. 
On Conditioning Day #3, THC+CIE exposed animals exhibit an increase in signal 
directly following each shock presentation (Figure 6-7).  









 When quantifying signaling change in response to the shock on Conditioning 
Day #3, THC+CIE exposed animals exhibit a heightened response to each of the 
shocks when compared to air exposed animals as well as those exposed to 
THC+CIE treated with NAC. Additionally, the magnitude of response observed in 
the THC or CIE exposed animals is lower than when animals are exposed to both 
drugs (Figure 6-8).  
 
 This difference between treatment groups as well as the difference between 
responses on Conditioning Day #1 versus Day #3 are revealed when comparing 
the average response to all shocks across each day (Figure 6-9). While the pattern 
in shock responses on Conditioning Day #1 is not clear, by Conditioning Day #3, 
group differences in signaling reflect the differences in freezing behavior shown in 
Figure 6-3. There is a significant effect of treatment observed [F (4, 70) = 15.02, 
p < 0.0001], where THC+CIE exposed animals exhibit a heightened PrL response 
to the shocks on Conditioning Day #3 when compared to all other treatment groups 




(Figure 6-9). Virus and probe location in the PrL are depicted in Figure 6-10 to 
ensure that all recordings were from within the boundaries of the PrL.  
 
 





 The results from these experiments indicate that THC and ethanol exposure 
during adolescence leads to increases in fear responses that are associated with 
a higher level of prelimbic signal in response to fearful stimuli. This effect was 
greater with combined drug exposure than either drug alone, and, when these 
animals were treated with NAC after each drug exposure, the behavioral and 
signaling alterations observed following adolescent THC and ethanol exposure 
were reversed. As such, these experiments identify the determinantal effects of 
adolescent THC and ethanol exposure on future behavioral and neuronal 
responses to fear stimuli. Further, these results support the hypothesis that 
alterations in prelimbic signaling may underlie the clinical relationship between 
adolescent drug exposure and development of PTSD.  
 These experiments examined pain sensitivity as an alternative explanation for 
the group differences observed with regards to freezing behavior, but there are a 
number of additional explanations that should be explored. First, exposure to these 
drugs could be causing a reduction in motor activity during fear conditioning 
paradigms that is recorded as increased freezing. While exposure to THC has 
been shown to cause short term decreases in motor activity observed in open field 
tests immediately following drug exposure, these are transient effects that are 
dependent on the drug being onboard and were not present 48 hours later 
(Bruijnzeel et al. 2016). Similarly, ethanol exposure has been shown to cause 
alterations in motor behavior, but these effects have been shown to dissipate 




following the cessation of ethanol exposure (Ornelas et al. 2015). These motor 
effects that occur as a consequence of ethanol exposure on motor sedation are 
also less severe in adolescent animals when compared to adults (Acevedo et al. 
2013, Little et al. 1996). As these experiments tested fear conditioning 18 days 
following the last THC exposure and four days after the last CIE session, we do 
not expect motor alterations as a result of these drugs to have impacted behavior 
during fear conditioning. While these experiments focused on alterations in 
prelimbic signaling, there are a number of fear related areas that could also be 
affected as a result of THC and ethanol exposure during adolescence. There are 
high levels of CB1 receptors in the amygdala, and cannabinoids are highly involved 
in signaling in this region especially in the basolateral amygdala (BLA) (Katona et 
al. 2001, Pistis et al. 2004, Phan et al. 2008). In general, adolescents exhibit 
stronger amygdala reactivity in response to fearful stimuli when compared to adults 
(Guyer et al. 2008). Additionally, it has been shown that adolescent cannabis users 
exhibit increased amygdala reactivity in response to fearful stimuli along with 
impaired discrimination between threat and neutral stimuli due to increases in 
prefrontal cortex activity (Spechler et al. 2015). Preclinical studies also support this 
effect, with animal models reporting inhibition of GABA transmission in the 
amygdala following exposure to CB1 agonists (Katona et al. 2001). Further, when 
animals were treated with THC and exposed to restraint stress, the effects on 
inhibitory transmission in the amygdala were enhanced (Patel et al. 2004). 
Therefore, while these experiments determined the effect of adolescent exposure 
to THC and ethanol on prelimbic cortex signaling during fear stimuli presentation, 




future examinations of neuronal alterations following adolescent THC exposure 
should include analysis of downstream amygdala activity.  
 These experiments determined that adolescent exposure to THC and ethanol 
leads to increased behavioral and neuronal responding to fear stimuli during fear 
conditioning. Additionally, NAC treatment administered directly after each drug 
exposure session was able to prevent both the increased freezing exhibited during 
conditioning as well as the heightened prelimbic signaling recorded following the 
presentation of fear stimuli. These results are in accordance with the hypothesis 
that adolescent drug exposure can induce neuronal alterations that may cause an 
increased predisposition for developing disordered responses to fear stimuli that 
underlie PTSD. Furthermore, the use of glutamatergic modulators to normalize 
glutamate homeostasis in the prefrontal cortex could serve as a potential treatment 























 The studies presented in this dissertation establish the detrimental effects of 
stress and drug exposure on multiple PFC-reliant behavioral tasks including drug 
seeking, cognitive flexibly, and fear-cue reactivity. Further, these experiments 
demonstrate that alterations in glutamatergic regulation in the prefrontal cortex are 
responsible for the drug and stress induced changes in responses to fear and drug 
cues. Finally, pharmacological modulators of glutamatergic function were used to 
reverse these stress and drug induced deficits.  




N-acetylcysteine prevents stress induced alterations in alcohol seeking and 
cognitive flexibly  
 Restraint stress exposure followed by testing in self-administration paradigms 
revealed a stress induced increase in ethanol seeking during acquisition, 
extinction, and stress cue induced reinstatement testing. Additionally, treatment 
with N-acetylcysteine (NAC) delivered either prior to, following, or surrounding 
restraint prevented the stress induced increases in ethanol seeking observed 
throughout self-administration. Stress exposure was also found to cause 
impairments in cognitive flexibility that were prevented with NAC treatment as well.  
 Previous studies have examined the relationship between stress exposure and 
drug seeking across a wide variety of clinical studies as well as in preclinical 
models. For these experiments, restraint stress was used as our stress model and 
self-administration modeled ethanol seeking, but a variety of different techniques 
for stress and drug administration have been tested. Alternate models have shown 
increased drug seeking following stress exposure for drugs such as 
methamphetamine, heroin, cocaine, and ethanol (Goeders and Geurin 1994, Liu 
and Weiss 2002, Lewis et al. 2013, Pizzimenti et al. 2017, Shaham and Stewart 
1994). In clinical studies, it has been shown that PTSD patients have an increased 
rate of substance use disorders when compared to the general population and are 
more likely to exhibit relapse events in response to stress associated cues 
(Roberts et al. 2015, Tipps et al. 2014, Shaham and Stewart 2000). Additionally, 
while those with PTSD and a co-morbid substance use disorder do not have 




increased severity of substance use, they do exhibit a higher incidence of relapse 
compared to those with a substance use disorder alone (Tate et al. 2004, Najt et 
al. 2011, Burns et al. 2010). These clinical and preclinical studies support the 
results presented here, in which exposure to a stressor leads to increased ethanol 
seeking throughout self-administration paradigms as well as increases in ethanol 
seeking during fear cue-induced relapse testing. Additional results presented from 
these experiments include examinations of stress effects on cognitive flexibly. 
While these experiments determined that restraint stress exposure resulted in 
deficits in cognitive flexibility, further reports in the literature have achieved mixed 
results depending on the time scale of testing. In clinical studies, those exposed to 
an acute stressor exhibited impairments in cognitive flexibility (Shields et al. 2016), 
but this relationship has been shown to be more complicated in animal models with 
impairments, enhancements, and no effects on cognitive flexibility reported in 
rodent studies (Butts et al. 2013, Thai et al. 2013, George et al. 2015). Therefore, 
due to the previous reporting of both stress induced increases in relapse-like 
behavior and impairments in cognitive flexibility, the novelty of these experiments 
comes from the use of N-acetylcysteine (NAC) to prevent these effects.  
 The overlap in cognitive control of ethanol seeking and deficits in set-shifting 
is in the prefrontal cortex (PFC) and, thus, stress induced changes in PFC function 
need to be examined to determine the possible mechanism of action NAC is 
working through. The promotion of drug seeking behavior and strategy set-shifting 
have been shown to be reliant on the medial prefrontal cortex (mPFC) with 




inactivation of the mPFC leading to increases in perseveration, similar to the 
results observed in these experiments (Birrell and Brown 2000, Floresco et al. 
2008). Additionally, stress exposure has a variety of deleterious consequences on 
the structure and function of the mPFC (Arnsten 2009, Holmes and Wellman 
2009). This region has been shown to be highly activated across a wide variety of 
stressors, leading to downstream increases glucocorticoid (GC) responses to 
stress (Ostrander et al. 2003, Herman et al. 2005, Singewald et al. 2003, Diorio et 
al. 1993). Further, exposure to stress and increases in GC activation are 
associated with morphological changes in these regions including dendritic 
remodeling (Liston et al. 2006, Sapolsky 2003, Cerqueira et al. 2005). These stress 
induced alterations in PFC structure have also been shown to be associated with 
modifications in glutamatergic functioning in this region (Popoli et al. 2011). The 
increase in GCs following exposure to physiological and environmental stressors 
is associated with increases in glutamate release in the PFC, and has been 
measured across multiple animal models including restraint stress, forced swim, 
foot-shock, and direct GC administration (Lowy et al. 1993, Moghaddam 1993, 
Musazzi et al. 2010). This increase in glutamate following stress is not only 
transient, since there are delayed and long-term effects on PFC glutamate function 
(Yuen et al. 2009, Yuen et al. 2011). Stress induced alterations in PFC glutamate 
are also associated with alterations in synaptic plasticity, including impairments in 
LTP in PFC to hippocampus signaling (Rocher et al. 2004, Mailliet et al. 2008). 
This is especially important for these experiments, as these signaling impairments 




are associated with deficits in PFC-reliant behaviors including cognitive flexibly 
(Cerqueira et al. 2007).  
 The results from these experiments determined that N-acetylcysteine (NAC) 
had the ability to prevent fear-cue induced relapse and impairments in cognitive 
flexibility that occur following exposure to an acute stressor. These results are 
supported by clinical studies that used NAC in veterans with co-morbid PTSD and 
SUD and recorded reductions in both drug use and PTSD symptoms following this 
treatment (Back et al. 2016). Additionally, NAC may be affecting stress induced 
impairments in prefrontal glutamatergic functioning to impart these effects (Dean 
et al. 2011). NAC has been shown to have a restorative effect on deficient 
glutamatergic systems as a result of drug exposure across multiple addiction 
models (Knackstedt et al. 2009, Madayag et al. 2007). Further, NAC has been 
shown to have effects on oxidative stress and inflammation in the brain which could 
serve as additional candidates for the mechanism of action at work in these 
experiments (Dean et al. 2011). While NAC has widespread effects on brain 
function, the glutamatergic or inflammatory systems in the brain could be a 
potential mechanism of action for these experiments due to the overlapping effects 
of stress on these processes. 
 In summary, these experiments determined that acute stress exposure leads 
to increases in ethanol seeking during self-administration and stress-cue induced 
reinstatement and leads to impairments in cognitive flexibility, both of which are 
prevented with N-acetylcysteine treatment surrounding the stressor. NAC may 




potentially be regulating glutamate homeostasis in the prefrontal cortex to impart 
these effects, but further studies are required to determine the exact mechanism 
of action. These results add to the established body of literature examining the 
detrimental effects of stress exposure on prefrontal cortex reliant cognition and 
provide further evidence to support the use of NAC in comorbid PTSD/AUD.  
 
Chronic ethanol exposure leads to deficits in fear extinction learning through 
alterations in mGlu5 signaling in the infralimbic cortex  
 This set of studies modeled PTSD/AUD in rodents using fear conditioning 
followed by CIE and found that ethanol exposure leads to impairments in fear 
extinction learning in both sexes. Additionally, using CDPPB and microinjections, 
these results determined that the effects of ethanol on fear learning are dependent 
on mGlu5 signaling in the infralimbic subregion of the prefrontal cortex. Further, 
these studies establish multiple sex differences with regards to responses to fear 
stimuli during conditioning and recall.  
 Increasing evidence has implicated the PFC in the extinction of both fear and 
drug-seeking behaviors. These converging lines of evidence from the fields of fear 
and drug research suggest that the PrL cortex functions as an “on-switch” for fear 
expression and drug-seeking, while the IfL cortex functions as an “off -switch” to 
allow for the expression of extinction behavior (Quirk et al. 2010; LaLumiere and 
Kalivas 2008; LaLumiere et al. 2010; Peters et al. 2009). While the majority of 
studies investigating the role of the PrL and IfL subregions support our current 




findings, there are a small number of published manuscripts that suggest 
alternative roles of these structures in extinction learning. For example, Marek and 
colleagues (Marek et al. 2018) have highlighted the impact of PrL to IfL projections. 
Specifically, the PrL has been shown to send excitatory afferents to neurons in the 
IfL, some of which project to the amygdala. Using c-Fos expression as a measure 
of neuronal activity, they found that PrL neurons that project to the IfL were active 
during extinction learning and optogenetic stimulation of these PrL to IfL afferents 
resulted in facilitated extinction learning (Marek et al. 2018). While these findings 
provide a greater role for the PrL in extinction learning, they still highlight the 
importance of these PFC subregions in extinction-related behaviors. Although not 
directly examined in the current set of studies there has been a substantial amount 
of research implicating areas of the amygdala in the extinction of fear conditioning 
(Quirk et al. 2010; Sierra-Mercado et al. 2011; Meyers and Davis 2002; Meyers 
and Davis 2007). In addition to extinction learning, a number of studies have also 
shown that subregions of the amygdala are involved in fear memory 
reconsolidation (Parsons and Gafford et al. 2006; Parsons, Gafford, and Baruch 
et al. 2006; Nader et al. 2000; Debiec et al. 2006; Doyere et al. 2007). Given the 
substantial impact that alcohol abuse has on both the PFC (Abernathy et al. 2010; 
Tu et al. 2007) and the amygdala (Koob 2009; Silberman et al. 2009; McCool et 
al. 2010), it is logical to assume that CIE alters the neurocircuitry between these 
brain regions, potentially causing the changes in extinction learning and memory 
recall that were observed in these studies. 




 These studies also established the ability of CDPPB, an mGlu5 positive 
allosteric modulator, to reverse CIE induced deficits in fear extinction learning. 
From a translational perspective, the glutamatergic system is one of the most 
investigated neurotransmitter systems involved in memory-based treatment 
approaches. Manipulation of both ionotropic and metabotropic glutamate receptors 
alters extinction learning of fear and drug-seeking behaviors as well as the 
reconsolidation of these memories (Gass and Chandler 2013; Cleva et al. 2010; 
Gass and Olive 2008; Meyers et al. 2011; Sorg 2012). However, given the negative 
side effects associated with direct NMDA enhancement, a focus has been placed 
on investigating the impact of mGluR manipulation on fear and drug memories. 
Generally, enhancement of mGluR activity has been shown to facilitate extinction 
learning for fear (Sethna and Wang 2014) and drug-seeking behaviors (Gass and 
Chandler 2013; Cleva et al. 2010; Singewald et al. 2014). Additionally, our lab has 
shown that positive allosteric modulation of mGlu5 facilitates the extinction of 
cocaine- (Gass and Olive 2009a; Cleva et al. 2011) and alcohol-seeking (Gass et 
al. 2014). Additional studies have focused on the role of mGlu5 in the prefrontal 
cortex on fear extinction. It has been shown that the consolidation of fear extinction 
memories is dependent on mGlu5 activity in the IfL and enhancement of this 
activity can contribute to fear extinction (Fontanez-Nuein et al. 2011). Furthermore, 
genetic deletion of mGlu5 leads to impairments in the acquisition and extinction of 
fear behaviors (Xu et al. 2009). In total, these studies all highlight the necessity of 
mGlu5 signaling in fear learning and extinction and utilize this function for the 
treatment of comorbid PTSD/AUD.  




 In support of the sex differences observed with regards to behavioral 
responses during conditioning and recall, these fear-related learning and memory 
processes have also been shown to differ between the sexes. Multiple lines of 
inquiry have found sex differences in fear responses that involve the medial 
prefrontal cortex. Further, these differences have been found in both behavioral 
and molecular studies. Behaviorally, sex differences have been established during 
fear conditioning (Fenton et al. 2016; Keiser et al. 2017), extinction (Voulo and 
Parsons 2017; Velasco et al. 2019; Matsuda et al. 2015), and recall (Baran et al, 
2009; Keiser et al. 2017, Shvil et al. 2014). Females have also been shown to 
exhibit more active fear avoidance strategies, such as darting rather than freezing, 
which could account for the behavioral differences observed in these studies 
(Gruene et al. 2015). Furthermore, while females in different estrous phases have 
been shown to extinguish fear behavior at the same rate, these same animals 
exhibit lower levels of freezing in recall testing when in proestrus compared to 
metestrus (Maeng et al. 2015). The determination of differential fear response 
strategies between the sexes is an important factor when examining behavioral 
data and would be a valuable analysis for further fear related studies. Additionally, 
there are a number of differences between the sexes in the circuitry and biological 
mechanisms responsible for fear learning (Ramikie and Ressler, 2017). When 
examining auditory fear memories, it has been shown that females exhibit 
enhanced learned fear expression that is associated with elevated gamma 
oscillations in the medial prefrontal cortex (Fenton et al. 2016). Gamma oscillations 
have been shown to play a role in memory processing in the prefrontal cortex and 




have been shown to be involved in fear learning in both preclinical (Fitzgerald et 
al. 2014) and clinical populations (Mueller et al. 2014). Therefore, innate signaling 
differences between males and females in the mPFC could be playing a role in the 
sex differences we observed during fear conditioning. The PFC is a sexually 
dimorphic brain area with females having large populations of estrogen receptors 
in this region (Almey et al. 2014). Estrogen has been shown to affect long term 
potentiation and synapses in the mPFC which could be involved in the underlying 
cause of multiple sex differences exhibited during fear learning processes (Galvin 
and Ninan 2014; Gupta et al. 2001; Shanmugan and Epperson 2014; Zeidan et al. 
2011). Sex differences have also been established in glutamatergic systems where 
females exhibit higher levels of glutamate when compared to males in a variety of 
brain regions, and there is differential glutamate expression across the estrous 
cycle (Wickens et al. 2018). Additionally, there are known interactions between 
estrogen receptors and metabotropic glutamate receptors in females (Tonn 
Eisinger et al. 2018; Kasten et al. 2019) that could affect the prefrontal cortex and 
therefore affect responses to fear stimuli. 
 In conclusion, these studies demonstrate the deleterious effects of chronic 
ethanol exposure on fear extinction learning and establish mGlu5 activity in the IfL 
as a potential mechanism of action through which ethanol induces these effects. 
CDPPB as a glutamatergic modulator was also shown to be effective at reducing 
the harmful effects of ethanol, and supports the use of glutamatergic modulation 
for the treatment of comorbid PTSD/AUD.  




Optogenetic inhibition of the prelimbic cortex during fear memory reconsolidation 
facilitates extinction learning in ethanol exposed animals 
 These studies were completed to examine the effects of prefrontal cortex 
manipulation following fear memory recall on future responses to fear stimuli. By 
optogenetically inhibiting the PrL cortex during fear memory reconsolidation, we 
were able to enhance extinction learning in a model of PTSD/AUD. These effects 
were specific to the PrL cortex, as repetition of this experiment with inhibition of 
the IfL cortex did cause any effects on fear extinction learning. Further, these 
experiments confirmed these results in both sexes and also led to long term 
changes in responses to fear stimuli during spontaneous recovery testing.  
 The acquisition and maintenance of psychiatric disorders such as PTSD and 
AUD rely on the fundamental principles of learning and memory. Based on 
classical theories of learning and memory, the environment in which the patient 
experiences the traumatic event can become a conditioned stimulus (CS) and the 
fear response that the person has to the trauma environment and cues will then 
become a conditioned response (CR). Further experiencing of the environmental 
cues can reinforce the association between the cues (CS) and the fear response 
(CR) which leads to PTSD symptoms such as such as re-experiencing the trauma 
through flashbacks and nightmares in response to trauma associated cues 
(VanElazakker et al. 2013). These principles are often applied clinically for the 
treatment of PTSD and AUD through techniques such as exposure therapy. 
Repeated exposure to the trauma-associated environment (CS) in a safe location 




can help decrease the fear response (CR) to these cues in a process known as 
extinction learning (Merlo et al. 2014). Subsequent cue presentation offers a 
unique period of time where intervention can be made to disrupt the association 
between the trauma associated cues and the fear response. However, when 
alcohol is used to self-medicate in response to the PTSD symptoms, there are 
deficits in extinction learning which render these therapies unsuccessful (Conklin 
and Tiffany 2002; Back et al. 2014). These results are replicated preclinically in 
studies that establish impairments in fear extinction learning following binge 
ethanol exposure (Smiley et al. 2020). Therefore, in situations where chronic 
alcohol exposure occurs following trauma exposure, supplemental therapeutics 
are needed to treat PTSD symptoms. The two clinical mechanisms for enhancing 
these processes include the enhancement of extinction learning and the blockade 
of fear memory reconsolidation (Giustino et al. 2016). Our previous study was able 
to treat the behavioral deficits that occur with co-morbid PTSD/AUD through the 
first strategy by using a pharmacological modulator of mGlu5 to enhance extinction 
(Smiley et al. 2020). The present study utilized the second mechanism by using 
optogenetics to block fear memory reconsolidation. By blocking the activity of the 
PrL during fear memory reconsolidation, we stopped the “fear promotion” input to 
the memory engram (Kitamura et al. 2017; Tonegawa et al. 2015; 2018). 
Therefore, when fear memory recall is induced through exposure to the fear 
associated cues and environment, PrL activity is reduced and, behaviorally, we 
record a reduced fear response. While invasive brain manipulation techniques are 
not practical for human use, there has been recent research into therapeutic 




agents that result in the inhibition of fear memory reconsolidation. For example, 
propranolol has become a popular pharmaceutical to use in conjunction with 
behavioral therapies to affect more successful treatment outcomes for PTSD 
patients by blocking fear memory reconsolidation (Giustino et al. 2016; Brunet et 
al. 2014; Schwabe et al. 2012). The data presented here provide novel evidence 
that the manipulation of fear memory reconsolidation is a viable treatment strategy 
for extinction learning deficits that are introduced through exposure to chronic 
alcohol following stress exposure in a model of comorbid PTSD/AUD. 
 Previous studies have found conflicting results regarding the effects of ethanol 
exposure on fear learning, but it is important to examine each study separately 
with regards to the specific model used for both fear conditioning as well as ethanol 
exposure. When animals were conditioned using six tone/shock pairings followed 
by injections of 30% ethanol for five days, ethanol exposure was found to cause a 
strengthening of the fear memories that were established during conditioning 
(Quiñones-Laracuente et al. 2015). These animals exhibited an increased freezing 
response when compared to vehicle injected animals across extinction training and 
in a single extinction recall test the following day. However, these effects were only 
displayed when extinction training occurred directly following ethanol exposure, 
since when extinction testing occurred 10 days following ethanol injections there 
was no change in freezing during extinction (Quiñones-Laracuente et al. 2015). 
The main differences between this previously published data and the results 
presented here are in the fear conditioning (12 tone/shock pairings vs. 6) and 




ethanol exposure (14 days vapor exposure to 100% ethanol vs. 5 days of injections 
of 30% ethanol). Supporting evidence comes from mouse studies that determined 
the ability of ethanol to cause changes in fear learning and the glutamatergic 
system. These experiments were completed using a similar CIE model that found 
that ethanol exposure resulted in increased levels of freezing during extinction and 
retrieval testing that was associated with increased dendritic arborization in the PrL 
(Holmes et al. 2012). Additionally, these studies showed that a shorter CIE 
paradigm was not able to induce these effects (Holmes et al. 2012). Thus, the 
more intensive paradigm used for these studies could lead to longer lasting 
changes in prefrontal glutamate signaling as well as behavioral responses to fear 
cues. 
 Taken together, these studies suggest that inhibition of the PrL, but not the IfL, 
during fear memory reconsolidation facilitates extinction learning and prevents 
increased freezing during memory reconsolidation in both male and female 
animals in a preclinical model of PTSD/AUD. These studies support the use of 
modulation of memory reconsolidation for the treatment of learning and memory 
deficits that occur as a result of exposure to stress and chronic alcohol and, further, 








Adolescent exposure to THC results in impairments in cognitive flexibly and 
increases in ethanol seeking in adulthood 
 Previous studies illustrate the long-term effects on cognition that occur as a 
result of chronic cannabis use during adolescence (Jacobus and Tapert 2014). 
Clinically, cannabis exposure during adolescence results in impairments in 
memory performance (Silva de Melo et al. 2005) that persist even after prolonged 
abstinence (Schwartz et al. 1989). Additionally, cognitive flexibility has been 
examined in preclinical models where set-shifting was tested following exposure 
to various models of prolonged cannabis exposure (Gomes et al. 2014, Szkudlarek 
et al. 2019). These studies found that, while adolescent exposure to cannabinoid 
agonists induces deficits in strategy set shifting (Gomes et al. 2014), adult 
exposure to THC does not result in alterations in this behavioral task (Szkudlarek 
et al. 2019). Further, clinical studies have determined the effects of alcohol, 
cannabis, and use of both substances on cognition and have found that 
concomitant use of alcohol and cannabis by adolescents leads to deficits in 
cognitive flexibility (Winward et al. 2014). Thus, the results reported from the 
present experiment are in accordance with the literature, and further these data by 
using a mix of THC/CBD at a concentration that is clinically relevant.  
 Additionally, prior studies have shown that cannabis exposure can impact 
drug use in the future (Chadwick et al. 2013). Longitudinal studies have shown that 
adolescent cannabis use will positively predict levels of alcohol use for the 
following year, and further studies determined that ~25% of illicit drug users have 




had previous cannabis exposure (Newcomb and Bentler 1986). This effect has 
also been shown to be dependent on cannabis exposure occurring during 
adolescence, with the associations between later drug abuse predicted by prior 
cannabis abuse decreasing with the age at which cannabis abuse began 
(Fergusson et al. 2006). This effect has also been exhibited preclinically as well, 
where rodents exposed to THC during adolescence increase self-administration to 
drugs of abuse in adulthood (Ellgren et al. 2007). Additionally, it has been 
previously established that adolescents in general drink more than adults in 
various preclinical models of voluntary ethanol seeking (Bergstrom et al. 2006). 
The results from these experiment support the hypothesis that adolescent 
exposure to THC will increase ethanol seeking while adult exposure does not have 
the same effect.  
 An added aspect of these studies is examination of the effects of NAC on 
cognitive deficits induced by adolescent THC exposure. NAC treatment concurrent 
with THC and CIE exposure was able to prevent deficits in cognitive flexibility as 
well as have an effect on THC induced increases in ethanol seeking. While NAC 
has been shown to affect a wide variety of brain systems, its function as a 
neuroprotective agent could be a potential mechanism for action for these effects 
(Tardiolo et al. 2018). NAC has been shown to cross the blood-brain-barrier in 
animal studies and can affect antioxidant pathways as well as regulate 
glutamatergic signaling (Farr et al. 2003). Due to THC and ethanol’s ability to 
impair glutamate homeostasis in the prefrontal cortex, the regulatory action of NAC 




on this system may be responsible for the pro-cognitive effects of NAC observed 
in these studies (Gilbert et al. 1991). 
 In summary, these experiments revealed that adolescent exposure to THC and 
ethanol leads to impairments in cognitive flexibility. This deficit was associated with 
perseveration in set-shifting testing. Furthermore, exposure to THC during 
adolescence leads to increases in ethanol seeking during self-administration. 
Finally, NAC was effective at preventing drug induced alterations in cognitive 
flexibility, potentially due to its effects on prefrontal glutamate homeostasis. These 
data provide further evidence of the detrimental effects of adolescent THC 
exposure on prefrontal cortex reliant behaviors and establish a treatment effect of 
NAC.  
 
THC and ethanol exposure during adolescence leads to heightened responding to 
fear stimuli through increases in prelimbic activity 
 To examine the effects of adolescent drug exposure on future response to fear 
stimuli, animals were exposed to vaporized THC and ethanol during mid-
adolescence before being tested in fear conditioning paradigms. The ability of NAC 
to impact drug induced alterations in fear responding was examined along with in-
vivo recordings from the PrL during the presentation of fear stimuli. These studies 
found that adolescent exposure to THC and ethanol results in heightened 
behavioral responding during fear conditioning along with an increase in PrL 
signaling in response to each shock presentation. Additionally, when NAC was 




administered concurrently with each drug exposure, the effects of THC and ethanol 
on both behavioral freezing responses as well as PrL signaling alterations were 
prevented. These studies revealed the deleterious effects of adolescent exposure 
to THC and ethanol and provide evidence of impairments in PrL function as a 
contributing factor that may underlie the clinical relationship between adolescent 
drug exposure and future susceptibility to developing PTSD following trauma 
exposure. 
 These results add to the present literature examining the effects of THC and 
ethanol on stress responses. Cannabis is commonly used in an attempt to 
decrease anxiety, but THC is known to be anxiogenic, especially when it is taken 
at higher concentrations (Sharpe et al. 2020). This relationship has been 
demonstrated across a wide variety of preclinical tests of anxiety and in clinical 
examinations (Rock et al. 2017, Raymundi et al. 2020). More recently, the long-
term effects of THC on anxiety disorders has become a topic of study. Clinical 
studies have examined this relationship by putting chronic cannabis users through 
a fear conditioning paradigm and found that, during conditioning, cannabis use 
was associated with increases in threat generalization to safety stimuli (Papini et 
al. 2017). This reduction in differentiation between safe and threatening stimuli was 
also associated with impairments in fear extinction (Papini et al. 2017). These 
effects have been further investigated preclinically in the adolescent population. 
Specifically, studies have shown that adolescent animals exposed to THC exhibit 
alterations in fear learning after being exposed to a stressor, but this effect was not 




observed when THC exposure occurred during adulthood (Saravia et al. 2018). 
Additionally, adolescent exposure to chronic ethanol has been shown to have 
variable behavioral effects on fear conditioning depending on the ethanol exposure 
paradigm, fear conditioning protocol, and timing of exposure. Due to varying 
ethanol and fear exposure paradigms, these studies have found no effects on fear 
conditioning (Broadwater and Spear 2013), impairments in learning during 
conditioning (Stephens et al. 2005), or heightened responding (Moberg et al. 2017) 
following ethanol exposure. By using chronic intermittent ethanol exposure 
followed by exposure to 12 tone/shock pairings during conditioning, our results 
provide novel data regarding ethanol’s ability to increase responding during fear 
conditioning.  
 The effects of THC and ethanol observed during the behavioral paradigms 
completed in these studies were associated with signaling alterations in the PrL 
subregion of the prefrontal cortex. Generally, activity in the PrL cortex has been 
shown to correlate with freezing behavior during conditioning paradigms (Burgos-
Robles et al. 2009). Exposure to either THC or ethanol during adolescence has 
been previously shown to alter the development and morphology of this region. 
During adolescence, the prefrontal cortex is uniquely situated to be affected by 
drugs of abuse that may affect the ongoing developmental pruning (Pattwell et al. 
2016). In rodent models, THC exposure has been shown to disrupt developmental 
processes in the PrL subregion of the prefrontal cortex by altering gene networks 
that are responsible for dendritic development (Miller et al. 2019). Specifically, 




overactivity at cannabinoid 1 (CB1) receptors in the prefrontal cortex during 
adolescence can lead to dysregulation of glutamatergic signaling at inhibitory 
interneurons leading to impaired development of these cells and ultimately 
resulting in downregulated inhibitory control in this region (Caballero and Tseng 
2012). These findings are paralleled by clinical data demonstrating that those with 
a history of adolescent cannabis exposure exhibit alterations in both functionality 
and volume of the prefrontal cortex (Medina et al. 2009, Orr et al. 2013). Similar 
impairments in prefrontal cortex development have been observed as a result of 
adolescent alcohol exposure (Squeglia et al. 2014). The prefrontal cortex is known 
to be especially susceptible to the deleterious effects of alcohol, and significant 
differences in both gray and white matter have been observed following adolescent 
alcohol use (De Bellis et al. 2005, Medina et al. 2008). Given the ongoing 
development of the PrL as well as the ability of THC and ethanol to affect this 
region, these alterations could underlie the behavioral and signaling alterations 
observed as a consequence of adolescent drug exposure in the present studies.  
 The overlap between THC and ethanol’s effects is most pronounced in the 
prefrontal cortex and, therefore, NAC could be working in this area to prevent the 
increased reactivity to fear stimuli observed in these experiments. In clinical 
studies, NAC has been shown to regulate glutamate levels in the prefrontal cortex 
(McQueen et al. 2018) as well as functional connectivity of these regions (Mullier 
et al. 2019). Additionally, NAC has the ability to promote regulation of glutamate 
homeostasis in patients with substance abuse, including adolescents that exhibit 




cannabis dependence (Gray et al. 2010). Therefore, given THC and ethanol’s 
effects on prefrontal cortex glutamate homeostasis, NAC could be acting through 
this pathway to reduce increases in prelimbic signaling and behavioral responding 
during fear conditioning following THC and CIE exposure.  
 In summary, these experiments determined that adolescent exposure to THC 
and ethanol results in heightened behavioral responding during fear conditioning 
that is associated with increases in PrL signaling in response to fearful stimuli. 
These results support the hypothesis that drug exposure during adolescence can 
lead to neurobiological alterations that cause a predisposition to developing fear 
cue related disorders such as PTSD, and that normalization of glutamatergic 
functioning in the PFC could serve as a pharmacological method of preventing 
these deleterious effects. 
 
Summary 
 The overall goal of this dissertation was to determine the effects of stress, 
ethanol, and THC exposure on behavioral and neuronal responses to future 
exposure to fear and drug cues. To this end, experiments were completed using 
multiple behavioral models of stress and drug exposure, including fear conditioning 
and restraint stress accompanied by ethanol self-administration, chronic 
intermittent ethanol, and exposure to vaporized THC. Surgical techniques 
including microinjections, optogenetics, and fiber photometry were also used to 
examine the activity of the prefrontal cortex during these behavioral tasks. Further, 




the pharmaceutical compounds CDPPB and N-acetylcysteine were used to 
prevent and reverse both stress and drug induced behavioral and signaling 
deficits. In total, the studies completed within this dissertation establish multiple 
behavioral deficits that occur as a result of stress and drug exposure, determined 
the neuronal localization of these effects in the prefrontal cortex, and used readily 
available pharmacological compounds to treat these impairments. These data 
supply valuable information regarding the underlying circuitry involved in common 
psychiatric disorders such as post-traumatic stress disorder and substance use 
disorder and help to further the field regarding the use of glutamatergic modulation 
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